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Summary of the thesis
Summary of the thesis
The  first  chapter  describes  the  general  introduction  to  the  self  assembly  of  amphiphilic 
copolymers  and their  self  assembled  structures  specially  highlighted  with nanoreactors.  General 
concept of oxidative stress, natural  antioxidant mechanisms and the recent strategies to improve 
antioxidant therapy are presented. Further, the motivation and concept of the thesis are also briefly 
presented.
In chapter two, the structure-activity realtionship(SAR) based on statistical analysis of all classes 
of already published copper based superoxide dismutase mimics (SODm) is investigated to distinguish 
the structural and geometrical specificity of  highly active SODm. This will serve to streamline further 
the  process  of  new drug discovery in  relation  with  SODm.  Combination  of  hyperfine  coupling 
constants  and  distortion  factors  from  EPR  as  structural  parameters  characterizing  the  first 
coordination sphere around the metal showed an almost linear relationship related to a high SOD 
like activity. 
Chapter three presents the synthesis and characterization of a copper complex of  6-(2-hydroxy-
benzaldehyde)  hydrazono-as-triazine-3,5-dione  (CuIIENZm).  CuIIENZm  studied  in  this  work 
showed a change from a di-copper complex in the solid state to a mono-nuclear complex in solution. 
The  superoxide  dismutase  and  catalase  like  activity  of  the  CuIIENZm  were  determined  by  a 
modified  version  of  the  conventional  Nitro  Blue  Tetrazolium  assay and  Amplex  red  coupled 
fluorescence assay. CuIIENZm were able to completely detoxify the superoxide radicals and related 
peroxides.
In chapter four, we investigate the development of  antioxidant nanoreators by encapsulating the bi-
functional  CuIIENZm inside polymeric vesicles made of  PMOXA-PDMS-PMOXA block copolymers. 
We ensured that polymeric vesicles were not affected by the encapsulation procedure as indicated 
by light scattering and transmission electron microscopy. In addition, the structural conformation of 
CuIIENZm was preserved inside  the  polymer  cavity,  as  demonstrated  by electron  paramagnetic 
resonance and UV-VIS spectroscopy.
Chapter  five  explains  the  detailed  study  of  cellular  interaction  of  CuIIENZm  containing 
nanoreactors in THP-1 cells. The internalization of the nanoreactor in THP-1 cells was studied by 
confocal laser scanning microscopy and flow cytometry and intracellular localization through TEM. 
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Summary of the thesis
No evident toxicity was found using MTS and LDH assays. As CuIIENZm remained active inside 
the  vesicles  therefore,  these  CuIIENZm-containing  nanoreactors  exhibited  efficient  antioxidant 
activity against  paraquat  mediated  oxidative stress in THP-1 cells.  Development  of this  simple, 
robust antioxidant nanoreactor represents a new direction in efficiently fighting oxidative stress. 
Chapter six briefly summarize the results and achievements of the research work. Further 
investigations are suggested.
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1. Introduction 
1.1. Copolymers
Block  copolymers  are  macromolecules  consisting  of  a  minimum  of  two  homopolymer 
subunits linked by covalent bonds or through an intermediate, non-repeating unit known as a 
junction block.[1]  Block copolymers can be classified based on the arrangement and order of the 
homopolymer  subunits,  which  are  normally  marked  as  A,  B,  C  etc.  The  architectures  of 
amphiphilic block copolymers exhibit the same variety as seen for homo polymers: linear, cycle, 
multi-arm star, comb, hyper-branched or dendrimeric shape. (Scheme 1) Amphiphilic (amphi: of 
both kinds; philic: having an affinity for) block copolymers consist of at least two subunits, one 
of them possessing hydrophilic properties while the other has a hydrophobic character. 
Scheme 1.  Possible amphiphilic block copolymer architecture:  A – AB – diblock,  B – ABA 
triblock, C – ABC – triblock, D – dendrimer shape, E – star-shape, F – grafted.
1.2. General introduction to self-assembly 
Self-assembly is a process by which a disordered system of components forms an organized 
structure or pattern due to local interactions between the components themselves, without any 
external  guidance.  Self-assembly  can  be  either  a  static  or  a  dynamic  process.  In  static self-
assembly,  the ordered structures form at equilibrium and may require energy to form ordered 
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structures, which are stable after they formed. In dynamic self-assembly, interactions can occur 
only when the system is dissipating energy in order to form the organized structures.
Self  assembly  takes  place  in  nature  as  a  spontaneous  process  to  generate  well  ordered 
biological structures or systems. For instance, self assembly of lipid bilayers leads to an increase 
in  detailed  internal  organization  of  the cell  membrane.  Other  biological  structures, including 
membranes, proteins, nucleic acids and viruses, are also natural self-assembled super structures 
formed through intermolecular and/or intramolecular interactions.  Proteins with a well-defined 
amphiphilic nature spontaneously form spatially-organized supramolecular structures to achieve 
biological functions. The mimicking of the self-assembly of biological structures has recently 
received attention for the creation of novel materials in the biomedical domain, especially in drug 
delivery approaches.
1.3. Self-assembly of amphiphilic block copolymers
Similar to conventional amphiphiles (lipids and surfactants),  hydrophilic and hydrophobic 
blocks confer the amphiphilicity to block copolymers.  The hydrophilic/hydrophobic nature and 
microphase separation of the amphiphilic copolymer chains can lead to molecular ordered super 
structures via self assembly,[2-4]  mainly driven by non covalent hydrophobic interaction such as 
hydrogen bonds and van der Waals interactions.  The solvent,  which is selective for only one 
block,  is  unfavourable  for  the other  block,  and this  triggers  the self  assembly process.[5] The 
covalent bond between the incompatible blocks prevents the macrophase separation.[6]  Different 
morphologies  of  copolymers  are  generated  by  the  self-assembly  process,  such  as  micelles, 
vesicles, tubes, rods, and lamellar structures. (Scheme 2)
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Scheme 2. Schematic representation of different morphologies generated by the self-assembly of 
amphiphilic copolymers: a) micelles b) rods c) vesicles d) tubes e) lamellar structures.
These  morphologies  can  be  obtaining  by  controlling  the  chemical  nature  of  the  blocks, 
copolymer concentration, temperature and the nature of the solvent.[7-9] The influence of polymer 
concentration  was  investigated  on  the  formation  of  PS-co-PAA  vesicles.  Only  a  polymer 
concentration greater than 0.6 wt. % generates vesicles.[10] While PS-co-PAA copolymers in DMF 
form spherical aggregates, in tetrahydrofuran or dioxane vesicles are then formed. This indicates 
the effect of solvents on supramolecular morphology.[11]  Self-assembly behavior of amphiphilic 
block copolymers has been found to depend on the weight fraction of the hydrophilic block as 
well. In the case of both poly (ethylene glycol)-poly (butadiene) (PEG–PBD) and poly (ethylene 
glycol)-pentaerythritol ethoxylate (PEG–PEE) copolymers, if the fraction of PEG is between 20 
% and 42 %, the copolymers will self-assemble into vesicles. If the copolymer is considerably 
more  hydrophobic,  with  a  fraction  of  PEO <  20  %,  the  immobile  hydrophobic  blocks  will 
sequester into solid-like particles. For fractions of PEO > 42 %, spherical micelles are typically 
formed.[12] 
The  main  feature  that  makes  amphiphilic  block  copolymers  attractive  for  drug  delivery 
applications is their chemical versatility,  allowing control of size and morphology of the self- 
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assembled  structures.[13,14]  Micelles  and  vesicles  are  of  major  interest  for  drug  delivery 
applications because of their appealing features, which fulfill the requirements for selective drug 
delivery. 
1.4. Micelles
It  has  been  reported  that  amphiphilic  diblock  copolymers  dissolved  in  a  solvent  that  is 
selective for one of the blocks will  self-assemble and form micelles  with a compact  core of 
insoluble blocks surrounded by a soluble corona composed of a soluble block.[15]  The micellar 
structures  can be generated  in  two different  forms based on the length of  the blocks.  If  the 
hydrophilic  block is  longer  than the hydrophobic part,  star  micelles  with a  small  core and a 
longer corona are formed.[16,17] Oppositely, a copolymer with a hydrophobic block longer than the 
hydrophilic will form a crew-cut micelle.(scheme 3)[18,19] 
Scheme 3. Micelle types formed depending on the ratio of hydrophilic and hydrophobic blocks 
of AB copolymer a) star-like micelle b) crew-cut micelle.
The  micellization  process  starts  as  the  concentration  of  copolymer  increases  to  reach  a 
critical value called the critical micelle concentration (CMC) and it starts to associate to form a 
micelle in such a way that the hydrophobic part of the copolymer will avoid contact with the 
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aqueous environment.  At the CMC, the solvent can be found inside the micellar core, which 
exhibits  a  larger  size  than  the  micelles  formed  at  higher  concentrations.[19]  At  those 
concentrations,  the  equilibrium will  favour  micelle  formation,  due  to  their  low energy state 
configuration, and the remaining solvent will gradually be released from the hydrophobic core, 
resulting in a decrease in micellar size. Polymeric micelles are generally more stable than those 
formed of lipids, with a remarkably lower critical micellar concentration (CMC).[3] 
Polymeric  micelles  have  emerged  as  potential  carriers  for  poorly  water  soluble  drugs 
because they can solubilize those drugs in their inner core and they offer attractive characteristics 
such as small size (nm range) and a tendency to escape from the Reticulo Endothelial System 
(RES).[2]  Hydrophobic  drugs  can  be  entrapped  in  the  core  of  block  copolymer  micelles. An 
extensive variety of drugs such as doxorubicin,[20] paclitaxel,[21] cisplatin,[22] indomethacin[23] were 
incorporated  into polymer  micelles  and studied for drug delivery applications.  However,  the 
physical stability of polymeric micelle is a critical issue, since rapid release of the incorporated 
drug may occur in vivo.[24]
1.5. Vesicles
Self-assembly  of  natural  phospholipids  in  aqueous  solutions  generates  the  formation  of 
liposomes. Similarly, copolymers with amphiphilic character have been used to generate vesicles. 
Vesicles  are  usually  spherical,  hollow  spheres  with  a  hydrophobic  bilayer  membrane  and 
hydrophilic internal and external coronas.  Polymer vesicles are more stable, robust and highly 
impermeable compared to lipid vesicles.[25] The hydrophobic part of the amphiphilic copolymer is 
protected within the bilayer with the hydrophilic part exposed to the inner and outer aqueous 
environments.[25]  Scheme  4  schematically  represents  the polymeric  vesicles  formed  by  self-
assembly of  (a) di and (b) triblock copolymers. 
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Scheme 4. Schematic representation of polymeric vesicles formed via self-assembly of (a) di 
block and (b) tri block copolymers.
The formation of vesicles occurs either through bilayer formation,[25]  or by a sequence of 
intermediates[26] during the self-assembly process. In the classical way, first copolymers form a 
bilayer  and,  secondly,  close-up  to  form  a  vesicle.  Contact  alone  between  the 
hydrophilic/hydrophobic  interfaces  is  often  sufficient  to  force  a  copolymer  system  to  form 
bilayers.  In another mechanism,  first  spherical  micelles  are formed,  then worm-like micelles. 
These  then  form  flattened  disk-like  micelles,  which  close-up  and  form  vesicles.  Bilayer 
formation followed by closing into vesicles, whether occurring spontaneously or during a series 
of intermediates, necessarily involves encapsulating the surrounding environment within the core 
of  the  vesicle.  Recently,  another  mechanism  has  been  postulated  on  the  basis  of  dynamic 
simulations,[27]   whereby small spherical micelles are initially formed because the segregation of 
the  two  blocks  lags  behind  copolymer  aggregation.  These  grow  to  large,  energetically 
unfavourable spherical micelles. They therefore re-structure to yield vesicles.[28]
The  size  of  vesicles  ranges  from nanometers  to  several  micrometers,  depending  on  the 
hydrophilic/hydrophobic  block  lengths  of  the  copolymer,  solvent  ratios,  concentration  of  the 
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polymer and method of preparation.[6,10,29,30]  In addition, the size of a vesicle can also depend on 
membrane thickness, with bigger vesicles having thicker membranes and smaller ones having 
thinner  membranes.  However,  no  influence  of  membrane  thickness  on  vesicle  size  has  been 
found for the majority of polymeric vesicles.[31]  The thickness, fluidity and permeability of the 
vesicular membranes can be controlled by tuning the copolymer compositions.[30] The stability of 
vesicles is an another important aspect to consider for technological and medical applications. To 
ensure that vesicle morphology is maintained and to prolong the circulation time in the body, the 
vesicle membrane is required to be as stable as possible.[32]
Polymeric  vesicles  have  been  widely  reported  in  the  literature  and  used  as  potential 
encapsulation  devices  for  water-soluble  molecules  due  to  the  large  internal  volume  of  the 
aqueous cavity. The chemical versatility of amphiphilic copolymers accounts for the generation 
of vesicles in a wide range of medium, from organic solvents to aqueous solution. The inner core 
of  the  vesicle  can  readily  accommodate  various  guest  molecules,  ranging  from  small  drug 
molecules to large protein molecules, by means of encapsulation.  In addition, the hydrophobic 
bilayer membrane can also be used to trap hydrophobic entities such as dyes in order to facilitate 
the tracking and imaging of these vesicles in their  roles as delivery and diagnostic tools.[33-35] 
Various targeting ligands can be attached to the surface of the vesicles, thereby increasing drug 
bioavailability, reducing undesirable side effects and minimizing nonspecific uptake. This then 
allows for specific targeting to certain cells within the cancer sites[36]  or even intracellularly to 
specific organelles. In this way, a therapeutic effect can be delivered to the appropriate biological 
compartment  in  a  so-called  active  targeting  strategy based  on  surface  functionalization  with 
ligands, for the targeting of receptors expressed at cell surfaces with highly specific interaction. 
1.6. Nanoreactors
Polymeric  vesicles  encapsulated  with enzymes  that  are able  to  act  in  situ are termed as 
nanoreactors. Such a system confers the advantages of protecting the enzymes from proteolytic 
attack and allows the enzymes to act in situ. In a nanoreactor, an enzyme reaction is restricted in 
the confined cavity, which is contrary to a conventional release system where the enzymes need 
to be released to catalyze the reaction. Thus, the necessity of release from the polymer cage, as 
with the conventional drug release carrier, is eliminated. Therefore, nanoreactors do not need an 
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optimization  process  to  control  the  release  profile  and  avoid  release  into  inappropriate  sub-
cellular compartments. 
The copolymer membrane of a vesicle has a greater membrane thickness as compared to the 
lipid  membrane,  and  thus  reduces  permeability  while  decreasing  fluidity  as  compared  to 
liposomes.[12]  In the case of nanoreactors, access by substrates is necessary so as to support an 
enzymatic  reaction  in  situ  for the  enzymes  that  are  encapsulated. Various  approaches  are 
available to support substrate and enzyme combinations inside a nanoreactor: i) co-encapsulation 
of  substrate  together  with  enzymes  ii)  designing  a  nanoreactor  that  includes  a  substrate-
permeable membrane, and iii) facilitating the substrate permeation by inserting channel proteins 
in the polymer membrane.[3] (Scheme 5)
Scheme 5. Schematic representation of a nanoreactor formed by the self-assembly of amphiphilic 
block  copolymers  a)  nanoreactor  containing  enzymes  b)  nanoreactors  with  channel  protein 
containing enzymes.
The function of a nanoreactor depends on the activity of the encapsulated enzyme and this 
should be preserved during the encapsulation procedure. The preparation techniques may impose 
mechanical  or chemical  stress on the enzymes,  with potential  loss of activity.  Studies on the 
catalytic properties of nanoreactors have proven that the enzymes not only maintain their activity 
inside,[37] but they lower Km, due to favourable interactions with the polymeric membrane. It has 
been reported that the enzymatic activity is influenced by vesicle size. The smaller the vesicle 
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size,  the  greater  the  activity  of  the  enzyme,  indicating  the  advantageous  interactions  of  the 
enzymes with the polymer membrane.[38]
These nanoreactors  act  as nanometer-sized reaction  compartments,  where one or  several 
different  enzyme  types  are  encapsulated  and  shielded  from  proteolytic  attack.[39]  Various 
copolymers  were  investigated  to  develop  nanoreactors,  namely,  poly(ethylene  glycol)-block-
oligo(desamino-tyrosyltyrosine  octyl  ester  suberate)-blockpoly(ethylene  glycol),[40] 
(poly(ethylene  oxide)-block-poly(dimethylsiloxane)-block-poly(2-methyloxazoline))[41]   and 
(poly(2-methyloxazoline)-poly(dimethylsiloxane)-poly(2-  methyloxazoline)).[40-42]   Nanoreactors 
served to perform specific  reactions  in the confined space for various enzymes  such as acid 
phosphatase,[37]  horseradish  peroxidase, nucleoside  hydrolase, thymidine  phosphorylase.  The 
enzymes are encapsulated in the aqueous cavity of nanoreactors, mainly intended for enzyme 
replacement therapy. More complex nanoreactors were formed by encapsulating two different 
enzymes to perform cascade reaction either inside the nanoreactors or within the membrane of 
the vesicles.[46] 
1.7. Membrane permeability of nanoreactors
The  permeability  of  the  polymeric  membrane  to  substrate  molecules  is  an  important 
parameter for the nanoreactors to perform catalytic reactions inside the aqueous cavity. Transport 
across  the membrane  can be achieved by incorporating  channel  proteins  in  the impermeable 
polymeric  membranes  or  by  using  a  substrate-permeable  membrane.(Scheme  5)  It  has  been 
shown  that  channel  proteins  can  be  successfully  reconstituted  in  amphiphilic  copolymer 
membranes  that  are  closely  identical  to  natural  lipid  bilayers.  The  copolymer  membrane 
thickness (~20 nm) is considerably greater than lipid bilayers (3 – 5 nm) and the  hydrophobic 
part  of  channel  forming  proteins  may therefore  be too small  to  fit  into  the  thickness  of  the 
polymer  membranes.  However,  the  high  flexibility  and  the  conformational  freedom  of  the 
polymer  molecules,  if  they  are  appropriately  designed  in  terms  of  hydrophobic  domain, 
hydrophilic/hydrophobic ratio, allow for an adaption to the specific geometric requirements of 
membrane proteins without considerable loss of free energy.[47]
 In the case of vesicles made of PMOXAn-PDMSm-PMOXAn, which have an impermeable 
polymer membrane,  different membrane proteins such as outer membrane protein (OmpF),[47] 
integral outer-membrane protein (Tsx),[44] transport protein (FhuA),[43]  aquaporin water channel 
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protein  (AqpZ),[48]  and ion channel  protein  (LamB)[49]  were reconstituted  to  support  diffusion 
through  the  membrane.  The  nanoreactors  with  channel  proteins  that  make  the  membrane 
permeable to the substrate have potential application in therapeutics. Nanoreactors represent a 
new  strategy  to  cope  with  the  necessity  of  increasing  the  concentration  of  the  enzyme  at 
biological sites without side effects or denaturation. The protein acts inside the nanoreactor and 
no release is required in order to obtain the biological effect. 
1.8. Oxidative stress
Oxidative stress is caused by an imbalance between the production of free radicals, such as 
reactive oxygen species (ROS) and reactive nitrogen species (RNS), and the biological system's 
ability to detoxify them efficiently.[50]  All forms of life maintain a reducing environment within 
their cells. This reducing environment is preserved by enzymes that maintain the reduced state 
through a constant input of metabolic energy. Disturbances in this normal redox state can cause 
toxic  effects  through the  production  of  reactive  oxygen  species  such  as  superoxide  radicals, 
hydrogen  peroxide,  and  hydroxyl  radicals that  damage  all  components  of  the cell,  including 
proteins,  lipids,  and  DNA.[51,52]   The  cells  are  exposed to  a  large  variety  of  ROS from both 
exogenous and endogenous sources (Scheme 6). Exogenous agents including ionizing and non 
ionizing radiation, ozone, xenobiotics, drugs, food, pollutants and toxins can indirectly produce 
ROS  in  cells. Although  the  exposure  of  the  organism  to  ROS  from  exogenous  sources  is 
extremely high, the exposure to endogenous sources is much more important,  because it is a 
continuous process during the life span of every cell in the organism. Mainly, the mitochondria 
serve as a major source of ROS production in cells.
 In addition,  cytochrome P-450 detoxification reactions,  phogocytic  oxidative bursts, and 
peroxisomal leakage can generate significant amounts of ROS.[53]  The continuous efflux of ROS 
from  endogenous  and  exogenous  sources  results  in  continuous  and  accumulative  oxidative 
damage  to  cellular  components  and  alters  many  cellular  functions.  In  humans,  increasing 
evidence suggests that the cumulative damage caused by ROS contributes to numerous diseases, 
such  as  atherosclerosis,  Parkinson's  disease,  heart  failure,  myocardial  infarction,  Alzheimer's 
disease, diabetes, rheumatoid arthritis, cancer and AIDS.[54-57]
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Scheme  6. Different  sources  of  reactive  oxygen  species  (ROS)  from  both  exogenous  and 
endogenous. 
1.9. Natural antioxidant mechanism
Various antioxidants exist in cells to regulate the concentration of free radicals to help the 
body. Cells are protected from oxidative stress by an interacting network of both enzymatic and 
non-enzymatic  entities.  The  main  antioxidant  defence  mechanisms  involve  families  of 
antioxidant enzymes such as superoxide dismutase (SOD), catalase (CAT) and peroxidases.[58-60] 
Various non-enzymatic small molecules, vitamins A, C, and E, and glutathione also contribute to 
cellular antioxidant defence. Other antioxidants include lipoic acid, mixed carotenoids, coenzyme 
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Q10, several bioflavonoid, and protein cofactors (folic acid, vitamins B1, B2, B6, B12). They act 
in synergy and against different types of free radicals.[61-64] 
The superoxide dismutase (SOD) family contains metal ion cofactors that, depending on the 
isozyme, can be copper, zinc, manganese or iron. SOD enzymes are present in almost all aerobic 
cells and in extracellular fluids. In humans, the Cu/Zn SOD is present in the cytosol, while Mn-
SOD  is  present  in  the  mitochondrion.  Cu/Zn-SOD  is a  dimeric-protein  with  two  identical 
subunits; each contains one copper and one zinc ion respectively. The copper is the active metal 
center involved in the catalysis process of the enzyme. The basic catalytic mechanism of Cu/Zn 
SOD  takes  place  in  two  steps,  first  superoxide  reduces  the  copper  center  of  SOD  to  form 
dioxygen and a  second superoxide  oxidizes  the copper  center  to produce hydrogen peroxide 
(Equation 1).[58] 
O2•–  +  Cu(II)Zn-SOD  →  O2  +  Cu(I)Zn-SOD 
O2•–  +  Cu(I)Zn-SOD  +  2H+  →  H2O2  +  Cu(II)Zn-SOD Equation 1
The end product of the reaction is H2O2, which is usually detoxified by catalase or various 
members of peroxidase family including glutathione peroxidase. Catalase converts the hydrogen 
peroxide into water and oxygen,  via either  an iron or a manganese cofactor.  This enzyme is 
localized in peroxisomes in most eukaryotic cells. The enzyme consists of four protein subunits, 
each containing ferric ions in the haem group. The ferric ions are oxidized by the first H2O2 to 
produce Fe+4. A second molecule of H2O2 reacts with Fe +4 to reform ferric ions and produce water 
and oxygen. (Equation 2).[59] 
H2O2 + [Fe(III)]-catalase → H2O + Fe(IV) -catalase
H2O2 + Fe(IV)] -catalase → H2O + Fe(III) -catalase + O2              Equation 2
Peroxidases have a high affinity for H2O2 and can detoxify H2O2 even in low concentrations. 
For  example,  glutathione  peroxidase  found  in  the  cytoplasm,  mitochondria,  and  nucleus 
metabolizes hydrogen peroxide to water by using reduced glutathione as a hydrogen donor by the 
oxidation of glutathione (GSH) to its oxidized form, glutathione disulphide (GSSG) (Equation 3).
[61]
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     Glutathione peroxidase
2 GSH + H2O2                                                        GSSG + 2H2O                           Equation 3
The synergic  action of the various antioxidant  enzymes  keeps concentration of ROS in cells 
relatively low and able to be detoxified normally by the organismal ROS defence.
1.10. Antioxidant therapy
When the ROS concentration  overwhelms the normal  level  of protection,  the antioxidant 
system is not able to regulate the total amount of ROS. In such a condition, the antioxidant system 
of the organism should be reinforced by the administration of external antioxidants to prevent 
deleterious consequences of oxidative stress. It is important to deliver antioxidant agents at the 
biological site where a high concentration of ROS is present for efficient antioxidant therapy.
1.10.1. Administration of antioxidant enzymes
The  clinical  importance  of  enzymes  in  preventing  ROS-related  disease  conditions  was 
shown  in  various  transgenic  animal  models  that  over  expressed  SOD  from  human  origin. 
Clinically,  SOD showed  a  beneficial  and  protective  effect  on  animal  models  with  different 
pathological conditions such as inflammatory conditions, Parkinson’s disease, cancer, ischemia-
reperfusion injuries in various organs like the heart, liver and kidney, and in pulmonary diseases.
[65-69]  The direct administration of native antioxidant enzymes does not show any effect on some 
pathological  conditions,  namely  Parkinson’s  disease  and stroke,  due  to  the  higher  molecular 
weight  that  prevents  the  permeation  through  the  blood-brain  barrier.  SOD  and 
catalase/peroxidase have tremendous catalytic activity that protects cells from oxidative damage. 
However, as a result of a number of factors including the short half-life in plasma of around six 
minutes for both SOD and CAT, cell impermeability that prevents the uptake of these enzymes 
and  effectiveness  inside  cells,  non-human  origin  causing  immunogenicity  problem,  high 
molecular  weight  and high cost  of these enzymes,  usage in  clinical  medicine  is  limited.[70,71] 
However, the role of SOD in preventing these clinical situations is demonstrated in transgenic 
animal models.[72]  
There are various drawbacks to the direct administration of SOD in fighting oxidative stress. 
It is know that SOD can be denatured and damaged in the presence of hydrogen peroxide, formed 
during the dismutation  of  superoxide  or spontaneously.[73]  In  order  to solve the problem,  the 
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Poznansky group cross-linked SOD with catalase,  which can scavenge H202. In experimental 
animal models, the conjugation of catalase to SOD has shown efficient recovery from oxidative 
stress.[74]  However,  the  heterogeneity  and  higher  molecular  weight  are  limiting  factors  for 
bifunctional enzyme efficiency.  Another example is the peroxidase incorporation with SOD by 
chemical mutation, generating a bi-functional enzyme that reacts to combat both superoxide and 
H202. However, the peroxidase activity and the stability of the bifunctional enzyme is minimal as 
compared  to  the  native  enzymes.[75]   In most  cases,  the  protective  effect  of  native  enzymes 
requires high concentration and continuous dosage forms to obtain optimal therapeutic effects.[76-
78] This requires other approaches than with the bi-functional enzyme obtained by conjugation of 
SOD with catalase or peroxidase.
Therefore, the administration of catalase or peroxidase together with SOD is necessary to 
convert the toxic, stable and cell membrane permeable H2O2  into non-toxic oxygen and water 
molecules. The balanced activity of these enzymes is important to have complete protection of 
the cells against oxidative damage. 
1.10.2. Administration of enzyme mimics
To  overcome  intrinsic  limitations  of  antioxidant  enzyme  administration,  considerable 
attention  is  being  paid  to  designing  low  molecular  weight  and  low  cost  synthetic  metal 
complexes such as SOD and/or catalase and peroxidase mimics. In designing such complexes, 
various synthetic approaches have been applied. A number of transition metal complexes, such as 
complexes of manganese,  copper, iron and combination of different metal  centers, have been 
investigated for enzyme-like activity.[79-82]  
Although many metal complexes have been studied as enzyme mimics, the majority display 
poor  thermodynamic  stability  and  enzyme-like  activity  at  different  physiological  pHs.  The 
release of metal ions due to the degradation or instability of complexes causes toxic effects.[83] 
Therefore, high stability constants are required to avoid dissociation of the metal complex in a 
biological  system.  Thus,  bio-distribution  and  clearance  of  the  metal  complex  as  well  as  its 
pharmacological specificity have to be taken into account when designing an enzyme mimic. 
In  addition,  most  of  the  reported  enzyme  mimics  have  significantly  lower  enzyme-like 
activity  as  compared  to  the  native  enzymes.  Another  key  issue  with  enzyme  mimics  is  the 
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solubility of metal complexes. Hidalgo and co-workers mentioned that 40% of metal complexes 
are  not  soluble  in  aqueous solution and that  stops further  development  from reaching  viable 
pharmaceutics.[84] 
1.10.3. Strategies to improve antioxidant therapy 
The direct administration of enzymes/mimics can lead to easy elimination from the blood[85] 
and rapid degradation in the gastrointestinal tract.[86] Different strategies have been followed to 
improve the bioavailability of antioxidants by changing the means of delivery of enzymes or 
enzyme mimics.  Various attempts have been made to deliver the enzymes/mimics by protecting 
them through covalent conjugation with poly(ethylene glycol) (PEG) or phosphatidylcholine[87,88] 
and  by  encapsulation  into  liposomes.[89,90]  However,  these  alterations  did  not  improve  the 
bioavailability  of  SOD,  due  to  an  excessive  covalent  modification  with  PEG  that  led  to  a 
decreased  level  of  SOD  activity.[91]  Additionally,  encapsulation  of  SOD  into  liposomes  has 
serious drawbacks, due to intrinsic characteristics of liposomes, such as mechanical instability, 
interaction with high-density lipoproteins, and a short circulation lifetime.[92] 
In order to solve this challenge it is necessary both to protect mimic molecules to preserve 
their  antioxidant  capacity  and  to  reduce  toxicity  that  results  from degradation  in  biological 
compartments.  In  this  respect,  liposomes  have  been  intensively  investigated  as  carriers  of 
enzyme or enzyme mimics (enzyme-m).[93-96]  For example, Mn-porphyrin (chloro(-(5,10,15,20-
tetrakis[1-hexadecylpyridinium-4-yl]-21H,23H-porphyrins)  used  to  modify  the  surface  of  1-
palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine  liposomes  preserved  approximately  25%  of 
native Cu/Zn SOD enzyme activity.[94]  Liposomes were modified with Mn-HPyP as a ligand to 
obtain  enzyme-like  activity  for  both  SOD and  CAT.  In  this  way,  liposomes  displayed  dual 
enzyme-like  function and  were  termed  LIPOzymes  (liposome  +  enzyme).  However,  the 
efficiency of detoxification O2•− and H2O2 influenced by the membrane characteristics.[95,96] 
Alternatively, SODm have been conjugated with polymers to increase their circulation half-
life  and  bioavailability.  The  polymerizable  SODm  prepared  from  copolymerized  Mn(III) 
Tetrakis[1-(3-acryloxy-propyl)-4-pyridyl]porphyrin  (MnTPPyP-Acryl)  cross  linked  with  poly 
ethylene glycol diacrylate (PEGDA) reduced ROS damage in implantation with retention of high 
levels  of  SOD mimicking  activity.  Only at  very high SODm concentration  compared  to  the 
native SOD enzyme was an increase in activity reported.[97]   Similarly polymer supported Mn-
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SODm were synthesized by cross linking the polymers (4-vinylimidazole, methacrylic acid) with 
Mn2+ ion to create the coordination sphere like in native Mn-SOD enzyme[100] , but this approach 
dramatically reduced activity to as little as 0.1 % of the initial SOD-like activity.   Moreover, 
synthesizing enzyme mimics that will have high catalytic activity and high stability together with 
low toxicity is still a challenging issue to be solved.
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1.11. Motivation and Concept 
The  main  focus  of  this  thesis  is  to  develop  an  efficient  antioxidant  system  to  fight 
oxidative stress. In this respect we designed and developed an antioxidant system based on 
several steps as follows,
i. Structure-Activity relationship (SAR) analysis  to design a  highly active  enzyme 
mimic
ii. Synthesis and Charaterization of a highly active enzyme mimic
iii. Encapsulation of the enzyme mimic in polymeric vesicle to generate antioxidant 
nanoreators
iv. Studying the cellular interaction of nanoreators containing enzyme mimics 
(i)  A  global  structure-activity  relationship  (SAR)  analysis  applied  to  all  classes  of 
compound  already  proposed  for  a  specific  biological  activity  is  a  essential  step  towards 
optimization  of  a  drug  development  strategy. Therefore  we  analyze  most  of  the  reported 
SODm statistically  to  determine  whether  spectroscopic  parameters,  which  characterize  the 
metal coordination, are consistently related to the activity of copper (II) complex to establish a 
structural model for a high SOD like activity. 
(ii) Based on SAR analysis, we have synthesis a copper (II) complex (CuIIENZm) derived 
from  triazine  ligands  with  a  high  enzyme  like  activities  that  could  be  dependent  on  the 
conformation of the metal binding region. The structure will be investigated both in the solid 
state and in solution. The detailed characterization of the structural and electronic properties 
of these CuIIENZm clearly is a necessary step to identify the specific structural  parameters 
that  induce a high SOD/Catalase-like activity.  This will  serve to focus the synthetic efforts 
only  on  relevant  aspects,  rather  than  on  factors  which  do  not  have  a  direct  influence  on 
activity.
(iii)  Recently,  the  concept  of  antioxidant  nanoreactors  was  introduced  based  on  the 
encapsulation of SOD in polymer vesicles through the self-assembly of amphiphilic copolymers 
(poly (2-methyloxazoline)-poly (dimethylsiloxane)-poly-(2-methyloxazoline) (PMOXA-PDMS-
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PMOXA) to improve the bioavailability.[99] The low solubility of the enzyme and its aggregating 
behavior not allowed to increase the concentration of SOD inside the vesicles therefore prevented 
the further improvement of the efficiency of the nanoreactors.  Here we extend the concept of 
antioxidant  nanoreactor  by encapsulation  of  a  CuIIENZm,  due  to  its  high  SOD/Catalase  like 
activities.  By  using  poly-(2-methyloxazoline)-poly(dimethylsiloxane)-poly(2-methyloxazoline), 
(PMOXA-PDMS-PMOXA)[99]  we ensure the system membrane is oxygen permeable and thus 
fulfills a double role: to shield the antioxidant agent and to enable agent and substrate to react 
inside  the  polymeric  “cage”.  In  this  way it  is  possible  to  improve  the  bioavailability  of  an 
antioxidant agent and to avoid the disadvantages of conventional drug release carriers, such as 
uncontrolled  release  of  the  antioxidant  agent.  The  chosen  block  copolymers  have  good 
biocompatibility,[100]  show  low  non-specific  protein  binding  due  to  the  hydrophilic  PMOXA 
block, and form vesicles with stable membranes that are impermeable to saccharide ions and 
water.[48] 
(iv)  To use, these nanoreactors in antioxidant therapy, studying the interaction with cells is 
essential  step.  In  this  way,  nanoreactor  containing  CuIIENZm are  tested  for  cellular  uptake, 
cytotoxicity and in vitro antioxidant activity in monocyte (THP-1) cells to assess conditions for 
possible biomedical applications against oxidative stress. This type of nanoreactors is proposed 
to function as versatile antioxidants, able to escape the immune system, for medical applications.
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2. Structure-Activity Relationship (SAR) analysis to design an 
efficient enzyme mimics
In  this  chapter,  we present  an essential  step towards optimization  of  drug development 
strategy:  a  global  structure-activity  analysis  of  compounds  already  proposed  for  a  specific 
biological activity. The statistical analysis can be applied to relate the structural parameters with 
biological activity for a family of drugs known as SODm that act as effective scavengers of the 
superoxide.
For several years, efforts have been made to design compounds with high Cu/Zn-SOD-
like  activity.  Numerous  copper  complexes  have  been  proposed as  Cu-SOD-mimics  (SODm) 
either as binuclear or mononuclear metal complexes based on different classes of ligands such as 
imidazole  derivatives,[101]  amine  derivatives,[101g,h,n,102]  pyridine  derivatives,[101c,g,m,v,w,102a-c,e,g,103] 
sulfonamide,[101a,104]  peptide  derivatives,[101q,r,105]  imine  derivatives,[102f,106]  salicylate  derivatives,
[101j,107]  cyclodextrin  derivatives,[108]  curcumin  derivatives,[109]  triazine  derivatives,[110] quinoline 
derivatives,[102h,105e,111]  and other classes.[112]  Although intensive efforts have been made to obtain 
better  Cu-SODm,  only  a  few  studies  that  have  tried  to  connect  the  SOD-like  activity  with 
structural parameters to model the interactions and conformations which promote a high SOD-
like activity. It has been established recently that there is a linear relationship between the log kcat 
for O2.- and the metal-centered electrode potential,[103c,113]  or that the modified distortion factor 
gZZ/PZZ obtained from EPR data can be correlated with the  activity trend.[110a,b] But these findings 
are  restricted  to  few  classes  of  ligands,  and  a  quantified  relationship  between  geometrical 
environment of the metal and the biological activity is still missing. 
2.1. Statistical SAR Analysis
By taking  in  account  most  of  the  Cu-SODm previously  synthesized,  we  statistically 
analyze  how the  spectroscopic  parameters  which  characterize  the  metal  coordination  can  be 
related to their biological behavior, in order to propose a structural model for a very active SOD-
mimic.  Due  to  its  property  of  allowing  fluxional  stereochemistry  and  variable  coordination 
numbers  between 4 and 6,  the Cu(II)  ion is  well  known to accommodate  a  large variety  of 
geometrical arrangements in its first coordination sphere; these influence the interactions with the 
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ligand atoms and consequently its physical-chemical properties and behavior.[114]  The sensitivity 
of the Spin Hamiltonian parameters to geometric changes in the coordination sphere of copper 
ion will give the possibility to connect their values with small changes in biological activity for a 
fine structure-activity screening,  that  cannot be obtained for other metals,  such as Mn or Ni, 
specific for other families of  superoxide dismutase, and used in SOD-m.[113,115]
The premise that we set out to test is based on the concept that the ligand dictates the 
catalytic activity by promoting or preventing a particular conformational structure. Consequently, 
we expect  that  the movement  of one of the first  coordination sphere nuclei  out of the plane 
defined for the axial site will change the ability of the corresponding complex to function as a 
catalyst. We constructed a database with the classes of copper SOD-m previously reported by 
taking into account various parameters obtained by EPR and electronic spectroscopy, and activity 
values, as determined with the indirect method, first reported by McCord and Fridovich.[116] Even 
though  the  indirect  assays  possess  inherent  problems  due  to  a  possible  participation  of  the 
compound being tested in a redox short circuit,[108a]  they represent the conventional way to test a 
SOD-like activity. We did not included in our database the complexes those activity was tested 
by other assays, such as pulse radiolysis, or stopped-flow kinetics[117a,b]  in order to have only one 
type of activity assay with its specific limits and errors, for all complexes. As activity parameter 
we took into account the concentration of copper complex required to attain 50% inhibition of 
the NBT reduction, the IC50 value, as it is indicative for its ability to catalyze superoxide radicals. 
Besides,  every IC50 value can be compared to that  of native SOD, or to other  SOD-m. We 
included in this database complexes from various classes of ligands: imidazoles, amines (di and 
tri amines), imines, sulfonamides, peptides, salicylates, quinolines, pyridines and mixed ligands 
(combinations  of any of the above mentioned ligands),  others (such as:  curcumin,  valporate, 
cyclodextrins, and triazines) and also their derivatives. 
Catalytic activity in Cu/Zn-SOD is expected to be favoured if the geometry of the first 
coordination sphere around the metal ion is imposed by the ligand in such a way that it facilitates 
superoxide binding to a vacant coordination site of the metal.[113] The copper has a sterically 
blocked axial site facing a hydrophobic region of Cu/Zn-SOD, whilst the active site, which is 
occupied  by water  in  the  native  protein,  faces  a  narrow hydrophilic  channel.  The  degree  of 
distortion at the copper site will therefore be influenced by the positions of the histidines in the 
protein and will have a direct effect on the size of the channel leading to the active site.[118] Such 
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structures,  accurately  determined  by X-ray diffraction  of  single  crystals,  do not  provide  any 
information on changes in the symmetry, which might occur in solution, the native physical state 
of superoxide dismutase. In this respect the spectroscopic characterization of copper environment 
in solutions by EPR and UV-Vis complete with details for specific conformations closer related 
with  the  biological  relevant  structures.  Therefore  we took into  account  in  our  screening  the 
hyperfine  coupling  constants  and  the  distortion  factors  from EPR and the  d-d-bands for  the 
electronic spectra, as parameters characterizing the first coordination sphere around the metal.
Even if a wide range of copper complexes are reported as SOD-m, the large distribution 
of IC50 values ranging from 0.1µM to more than 200µM, made us to sort the compounds in two 
clusters:  active  complexes  (IC50 ≤ 0.8µM),  and  non-active  ones  (IC50 between  0.8µM  and 
200µM). Compared with the native SOD activity, reported to have an IC50 of 0.04µM, we choose 
the cluster of active SOD-m to not show a dramatic decrease in activity as is the case of the 
compounds classified as non-active.  The cluster of non-active compounds is by far bigger than 
that  of  active  compounds  due  to  the  basic  requisites  of  functional  SOD-m  including  an 
appropriate geometry of the metal coordination sphere, biocompatible metal redox couples and 
adequate stabilities for low-toxicity, which represent a difficult task to attain.
2.2. Analysis of individual spectroscopic parameters
First we analyzed the variation of IC50 values corresponds to the SOD like activity as 
function of single spectroscopic parameters, including the wavelength of d-d transitions in UV-
Vis spectra- λ, the z component of the hyperfine interaction, Azz, and the ratio gzz/Azz (so called 
distortion  factor  F), obtained  from  the  EPR  spectra.  A  large  distribution  of  activity  values 
characterizes  the  whole  group  of  reported  complexes,  without  any  specificity  which  could 
involve a characteristic trend, both in the case of  λ (Figure 1 – a,b), and for each of the EPR 
parameters  (Figure  2  –  a,b,c,d). We  could  not  correlate  any  of  the  individual  structural 
parameters (d-d transitions, hyperfine interaction, or distortion factor) of Cu-SODm with their 
SOD-like activity. This indicates that individual spectroscopic parameter may not be the involved 
in contributing the higher SOD-like activity.
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Figure 1. a) SOD-like activity as function of maximum of the d-d transitions in electronic spectra 
() for all classes of Cu-SODm. b) closer look containing only the active compounds. 
 
Figure 2. a) SOD-like activity as function of the distortion factor f for all classes of Cu-SODm. 
b) closer look containing only the active compounds.  c)  SOD-like activity as function of the 
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parallel  hyperfine  coupling  constants  (Azz)  for  all  classes  of  Cu-SODm.  d)  Closer  look 
containing only the active compounds. Black square: non-active compounds; red stars - active 
compounds.
2.3. Analysis of combination of spectroscopic parameters
We expand the analysis by taking into account the combinations of structural parameters: 
λ & Azz, λ & F (Figure 3 – a, b), and Azz & F, respectively (Figure 3c) in order to see if there 
are  specific  domains  that  could  be  connected  with  the  active/non-active  clusters  of  SOD-m. 
However  no correlation  was  found  that  promote  higher  SOD  like  activity.  The  3D  graph 
combining the electronic transitions and each of the EPR parameters as function of SOD like 
activity do not show a specific trend which could allow to distinguish between the active and 
non-active compounds. But the 3D graph combining the EPR parameters with the IC50 values 
(Figure 4 – a,b) indicates for the active complexes an almost linear relationship, which cannot be 
put into evidence for the cluster containing the non-active ones. The similar trend was previously 
reported for the SOD-m copper complexes with triazine (asymmetric and symmetric) ligands.[110] 
However this linear relationship is general, and do not relate on specific ligand classes. 
Figure 3. a) d-d transition (λ) as a function of parallel hyperfine coupling constant (Azz) for all 
classes of Cu-SODm b) d-d transition (λ) as a function of distortion factor f for all classes of Cu-
SODm. c) parallel hyperfine coupling constants (Azz) as function of the the distortion factor f for 
all classes of Cu-SODm.
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Figure 4. SOD-like activity as function of maximum of the d-d transitions in electronic spectra 
(λ) and of the parallel hyperfine coupling constants (Azz) for non-active compounds a), and for 
active compounds b). SOD-like activity as function of the parallel hyperfine coupling constants 
(Azz) and f for non-active compounds c), and for active compounds b).
2.4. Role of coordination numbers
By taking into account all SOD-mimics, which were published and characterized from the 
point of view of their electronic and EPR parameters, our focus is on the relation between the 
geometry of the first coordination sphere around the metal  and its biological  activity.  As the 
coordination number of copper should make a difference in complexes’ behavior, because a four-
coordination  sphere provides  a  different  geometry for superoxide  radical  to  access  the metal 
compared with the fifth-coordination one, therefore, we also refined the analysis of the cluster of 
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active  compounds to include a  function of coordination  number  and  we classified the active 
compounds as function of 4- or 5- coordination numbers (Figure 5). Both groups of compounds 
show an almost linear relationship and we fit each of them by a linear regression (Table 1).
Figure  5.  3D representation of Azz,  f  and coordination number of copper, N for active Cu – 
SODm a). Hyperfine coupling constants Azz as function of the distortion factor f for active SOD-
m  b).  Black  stars:  5-coordinated  copper  complexes,  black  squares:  4-coordinated  copper 
complexes.
Metal sphere A b r* σD*
4-coordination 277.2 ± 2.5 -0.84 ± 0.03 0.992 2.46
5-coordination 331.7 ± 20.3 -1.18 ± 0.15 0.961 7.83
* r – correlation factor, and σD – standard deviation.
Table 1. Parameters of the linear regression fit of F factor as function of the hyperfine coupling 
constant, Azz (F = a + b x Azz).
The overall  EPR data suggest that  the cluster  of complexes with a 4-coordination sphere 
around metal contains by far the biggest number of compounds (around 50% (all active)  77% 
(according to the figure 5a) of the whole number of active compounds), and the square planar 
geometry with slight distortion induces, in general, higher catalytic activity than other geometries. 
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A smaller number of complexes with 5-coordination number ware active (around 44% (all active) 
23%  (according  to  the  figure  5a) of  the  whole  number  of  active  compounds),  and  no  6-
coordination number complex was active, indicating that there is a geometric specificity for an 
active SOD-m compound.
2.5. Role of ligand specificity
As we looked into the activity relationship with specific ligand classes, although we could 
not find exact correlation, it seems that imidazoles, sulfonamide and peptide based Cu-SODm are 
almost active.  The imine,  amine and pyridine derivatives having higher number of non active 
complexes.  We could  not  conclude  on  ligand  class  -  activity  relationship,  because  all  ligand 
classes having both active and non active complexes. The reason could be due to the important 
role played the structural parameters than the ligand specification.
Majority of the active Cu-SODm were mononuclear irrespective of the coordination number, 
contrary to many literature reports which claim that binuclear structure is important to have a 
better SOD mimicking activity. After a detailed look into various comparative data between active 
mono  and  binuclear  Cu-SODm,  we  consider  that  it  is  not  necessarily  to  have  a  binuclear 
compound, in order to get a high active SOD-m.  The assumption that the binuclear compounds 
are more active that the mononuclear ones is related to the analogy of the metal binding region of 
the  enzyme  which  contains  a  copper  and a  zinc  atom,  but  this  do  not  represent  a  structural 
requirement for a highly active compound. Besides, biological assays indicated that the role of Zn 
in native SOD is more related to the stability of the metal binding region, than to the catalytic 
activity.  However, in the future synthetic efforts should be able to focus on potential compounds 
identified  by theoretical  methods  as  possessing  physical  properties  that  correlate  with  a  high 
probability of possessing biological activity.
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3. Synthesis and characterization of bi-functional enzyme mimics 
Metal  complexation  of  6-(2-hydroxy-benzaldehyde)  hydrazono-as-triazine-3,5-
dione (L) was performed in a modified  approach of an earlier  procedure.[119]  L (1mM) was 
dissolved under stirring in 20 ml NaOH (0.05mM) at 40°C and the pH was adjusted to 7.5 with 
NaOH (1M). A solution of CuCl2 ⋅2H2O (1mM) in 5ml of milli-Q water was added slowly drop 
wise for 20-30 minutes at 40°C. The mixture was cooled to 4°C and stirred continuously for 1 
hour  under  atmospheric  pressure,  forming  a  green  precipitate.  The  precipitate  was  filtered, 
washed successively with hot water, ethanol and acetone and was dried. The powder was re-
crystallised in DMSO by slow evaporation method and formed small crystals after more than 2 
months at room temperature. 
 3.1. Solid-state structure of the CuIISODm 
3.1.1. IR spectroscopy
The characteristic peaks in the IR spectra of the powder of the  free ligand L and 
its copper complex were compared to distinguish the probable coordination points of the ligand 
(Figure 6 and Table 2). Coordination of oxygen to the copper atom in the Cu IIENZm follows 
from the shift towards higher wavenumbers of the phenolic v(O-H) peaks in the IR spectrum of 
the copper complex (~3300-3355 cm-1) when compared with the free ligand (~3250-3280 cm-1), 
together with the appearance of a new peak at 1210 cm-1, assigned to v(C-O). The shift towards 
lower wavenumbers of the IR peak atributed to v(CH=N) from 1648 cm-1 (free ligand) to 1631 
cm-1 (CuIIENZm) and the shift towards higher wavenumbers of the peak of v(C=N) from 1565 
cm-1 (free ligand) to 1584 cm-1 (CuIIENZm) support the metal binding of an imine nitrogen and 
a triazine nitrogen,  respectively.[120]  In addition,  the new peaks at 490 cm-1 and 415 cm-1 are 
assigned to Cu-O and Cu-N, respectively.[121] 
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Figure 6. IR spectra of free ligand (solid lines) and CuIIENZm (dashes) in powder form.
Compound IR (cm
-1)
 v(OH)       v(CH=N)      v(C=N)      v(NH)      v(C=O)
L ~3250-3280   ~1648      ~1565       ~3150      ~1680
Copper 
complex
~3300-3355    ~1630      ~1584       ~3150      ~1682
Table 2. IR-spectroscopic data for the free ligand L and the related CuIIENZm (powders)
3.1.2. X-ray crystallograpy
The molecular structure of the complex is presented in Figure 6. In the crystal, the 
compound forms a binuclear copper(II) complex being located on the inversion center 0.5, 0.5, 
0.5, of the space group P-1. Each copper ion is five coordinated through two bridging chloride 
ions,  two  nitrogen  atoms  and  one  oxygen  atom from  the  as-triazine  ligand,  which  form  a 
coordination sphere around the metal with a distorted square pyramidal geometry (Figure 7). 
The equatorial positions are defined by one triazine nitrogen atom, one imine nitrogen atom, 
one oxygen atom from the hydroxy group and one bridging chloride anion. The elongated axial 
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position is occupied by the second chloride anion, which is basal to the second copper of the 
dimer. 
Figure 7. ORTEP diagram of the crystal structure of the CuIIENZm under study.
The crystallographic details are summarised in Table 3 and selected interatomic distances and 
angles of the copper complex are presented in Table 4.
Empirical formula 
M
Temperature/K
Wavelength/Å
Crystal system
Space group
a/ Å
b/ Å
c/ Å
α/°
β/°
γ/°
Volume/ Å3
Z
dcalc/Mg m-3
F (000)
Measured reflections
Measured reflections
Measured reflections
Rint
wR(all data)
C28H40Cl2Cu2N10O10S4
1000.2
123
0.71073
triclinic
P ī
8.2044(5)
10.5939(6)
12.6014(7)
111.339(2)
97.147(2)
99.073(2)
987.54(10)
1
1.686
514
6575
3974
2607
0.033
0.0623
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Goodness-of-fit
δρmax/min/ e Å−3
1.1069
0.77, - 0.47
Table 3. Crystal data and structure refinement details of CuIIENZm.
Bond lengths/ Å Bond angles/ °
Cu1-N1 1.964(3) N1-Cu1-N5 79.57(12)
Cu1-
N5
2.000(3) Cl1i-Cu1-N5 89.48(9)
Cu1-O1 1.900(2) Cl1i-Cu1-N1 113.64(9)
Cu1-Cll 2.308(1) Cl1-Cu1- N5 95.03(9)
Cu1-Cl1i 2.645(1) O1-Cu1-N1 91.90(11)
Cu1-Cu1i 3.468(1) O1-Cu1-N5 170.66(12)
Cl1i-Cu1-O1 90.49(8)
Cl1i-Cu1-Cl1 91.40(3)
Cl1-Cu1-O1 94.31(8)
Cl1-Cu1-N1 154.16(9)
Cl1i -Cl1-Cu2 88.60(3)
Table 4. Selected bond distances (Å) and the angles (º) for the CuIIENZm under study.
The bond distances between copper and the first order donor atoms of the ligand (Cu1-N1= 
1.964(3) Å, Cu1-N5= 2.000(3) Å, Cu1-O1= 1.900(2) Å and Cu1-Cl1= 2.308(1) Å) are typical for 
the  square  base  of  pyramidal  Cu2+ complexes.[99f]  The  molecular  structure  is  in  addition 
stabilized  by  intramolecular  hydrogen  bonds  (N4-H4…O1i;  i  =  1-x,  1-y,  1-z  and  N4-O1  = 
2.952(6) Å).  A global  view of the crystal  structure of CuIIENZm is shown in Figure 8,  and 
indicates  the  interactions  present  in  solid  state  of  this  compound.  There  are  two  hydrogen 
bonds linking solvent molecules with each ligand molecule  (N2-H2…O5  , N2-O5  = 2.660(6) Å, 
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N3-H3…O4,  N3-O4  = 2.714  Å).  The  distance  between  neighbouring  complexes  of  3.417  Å 
accounts for π-π interaction, which stabilizes a chain system along the crystallographic a axis.
(figure 9)
Figure. 8 Packing scheme of the crystal of the CuIIENZm under study. View slightly off the 
crystallographic a-axis. Hydrogen atoms have been removed for clarity. 
Figure. 9 The distance between neighbouring copper complexes along crystallographic a axis.
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3.2. Structural changes upon dissolution of the CuIIENZm
3.2.1. UV-Visible spectroscopy
As the biological  relevant  conditions  for Cu,Zn-SOD (and thus also CuIIENZm) are  in 
solution, we determined whether and how the solid-state structure of the metal-binding region 
changes upon dissolution in dimethyl sulphoxide (DMSO). The electronic absorption spectra of 
free  ligand and the  copper  complex  at  ambient  temperature  are  presented  in  Figure  10  and 
Table 5. The electronic absorption band at 353 nm (ε = 11706 cm-1M-1) with a shoulder at 380 
nm corresponds to π-π* intra ligand transitions. LMCT band of the copper complex is present 
at 428 nm with a shoulder at 482 nm.[122] The weak and broad absorption band at 678 nm (ε = 
136 cm-1M-1)  represents  the  d-d transition  and suggest  a  predominantly  4-coordinated  metal 
sphere  with  a  distorted  square  planar  geometry.  However,  additional  weak  axial  ligations 
cannot be ruled out on the basis of these data.
Figure  10. UV/Vis absorption spectrum of a DMSO solution of the CuIIENZm under study.
39                           Enzyme Mimic to Develop Antioxidant Nanoreactors: From Synthesis to Application 
 Synthesis and characterization of bi-functional enzyme mimics
Compound λmax
(nm)
 ILT           LMCT            d-d                            
L  303                -                  -                      
Copper complex 353,             428,              678 
380(sh),      482(sh)                    
Table  5.  UV/Vis  absorption  spectra  for  the  free  ligand  L and  the  related  CuIIENZm  (in 
solution)
3.2.2. EPR spectroscopy
In order to gain more insight into the structure of the CuIIENZm  in solution,  different 
EPR experiments were undertaken. If the dicopper structure as found by the XRD analysis is 
retained in solution, strong exchange coupling is expected to occur between the two Cu II ions. 
Figure 11 shows the X-band CW-EPR spectrum of a frozen DMSO:toluene (1:1) solution of 
CuIIENZm with its simulation. 
Figure 11. (a) Experimental X-band CW EPR spectrum of a frozen DMSO:toluene (1:1) solution 
of CuIIENZm taken at a 100 K. (b) Simulation of (a) using the parameters in Table 6.
It  was found that  DMSO formed a bad glass leading  to  local  clustering of  the copper 
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complexes as is exemplified by figure 12. The broad signal underneath the type-2 Cu II EPR 
spectrum is due to clustered copper complexes. The relative contribution of this broad signal 
increased  upon increase  of  the  concentration  of  the  CuIIENZm.  Addition  of  toluene  largely 
solved this problem. Note that the complex was not soluble in pure toluene.
Figure  12.  X-band  CW-EPR  spectra  of  the  CuIIENZm  in  frozen  DMSO  and  in  frozen 
DMSO:toluene.
The principal  g and copper hyperfine values (Table 6) are typical of a type-2 mono CuII 
complex,  i.e.  a  square  planar  ligation  of  the  CuII ion  with  possible  additional  weak  axial 
ligations.[123]  This  confirms  the  UV/Vis  data  and  implies  rupture  of  the  original  structure. 
Similar breaking of the chloride bridges with subsequent rearrangement of the geometry of the 
Cu(II) center in solution compared to the single crystal structure has already been observed for 
other SODm and linked to their  SOD-like activity.[124]  The structure of the CuIIENZm under 
study thus differs from the tetrahedral surrounding of the copper ion found in bovine Cu,Zn-
SOD (characterized by the smaller Az value). The principal g and copper hyperfine values of the 
CuIIENZm resemble more those of lyophilized bovine Cu,Zn-SOD, whereby the imidazolate 
bridges between the copper and zinc ions are broken.[125]  
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Compound gx,gy gz
Ax,Ay 
(MHz)
Az
(MHz)
CuIIENZm 2.057
(±0.004)
2.266
(±0.001)
5
(±20)
-525
(±2)
[Cu(L1)2(NH3)2].2
MeOHa
2.05 2.27 - -516
[CuA]2+b - 2.310 - -510
Cu–carcc - 2.247 - -560
Bovine Cu,ZnSOD 2.08 2.262 - -401
Lyophilized bovine 
SOD
2.06 2.26 - -450
a[Cu(L1)2(NH3)2].2MeOH,  (HL1=  N-2-(4-methylphenylsulfamoyl)-6-nitro-
benzothiazole),, b [CuA]2+ , A = Ac-HisValHis-NH2,c Cu-Carcinine.
Table 6. Principal g and copper hyperfine values of CuIIENZm in comparison with SOD, other 
SOD mimics.
Peisach and Blumberg[123] showed that the gz and copper  Az values reveal information on 
the type of ligating atoms. Although this method is very course, the parameters of CuIIENZm 
agree  with  a  1N3O,  2N2O  or  a  3N1O  surrounding.  Based  upon  the  XRD  single  crystal 
structure, a likely model of CuIIENZm in solution will be as given in Scheme 7. As the bond 
length of Cu-Cl1 (2.308(1)Å) in the solid-state  structure of CuIIENZm is significantly larger 
that  the  bond  lengths  of  Cu-N  and  Cu-O  (1.964(3)  Å,  and  1.900(2)  Å,  respectively),  we 
suppose  that  the  Cl- anion  is  easily  detached  from the  CuII atom in  solution,  as  previously 
reported for other complexes.[101d]  X in Scheme 1 is therefore most probably a DMSO solvent 
molecule. Note that a weak axial ligation of solvent molecules to the CuII complex cannot  a 
priori be ruled out.
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Scheme 7. Schematic representation of CuIIENZm in solution with X = most probably DMSO. The 
nuclei  that  are  of  importance  in  the  discussion  of  the  EPR  data  are  indicated  by  numbering 
(nitrogens) and lettering (protons).  
In  order  to  obtain  more  detailed  information  on the CuIIENZm complex  in  solution,  a 
number  of  pulsed  EPR  experiments  were  set  up.  Figure  13a  shows  the  Davies-ENDOR 
spectrum  of  a  frozen  DMSO:toluene  solution  of  CuIIENZm  taken  at  an  observer  position 
corresponding with g≈gx,y=g⊥.  Weak mw pulses  were  used,  so  that  mainly  the  weak proton 
couplings are visible in the spectrum. These weak proton interactions can be largely suppressed 
using  strong  microwave  pulses,  so  that  the  stronger  interactions  can  be  studied  (hyperfine 
contrast  selective  ENDOR[126]   Figure  13b).  Several  contributions  to  the  ENDOR spectrum, 
stemming from different nuclei,  are visible in the latter  spectrum. A pair  of signals split  by 
about 15 MHz and centered around the proton Larmor frequency can be clearly distinguished. 
Similar signals were observed at other observation positions. Furthermore, corresponding cross 
peaks  are  found  in  the  different  X-band  HYSCORE spectra,  confirming  that  these  nuclear 
frequencies are linked to one type of proton nucleus (Figure 14a). Simulation of this proton 
ENDOR contribution (Figure 13c) reveals a largely isotropic hyperfine interaction (Table 7). 
The hyperfine coupling is in the same order of magnitude of what has been found for the imine-
type  protons  of  bis-(salicyldoximato)  copper(II)[127]  and  N,N’-ethylene  bis-
(salicylideniminato)CuII[128]  (Table 7). This indicates that we can ascribe this interaction to the 
imine proton labeled as Ha in Scheme 7. 
43                           Enzyme Mimic to Develop Antioxidant Nanoreactors: From Synthesis to Application 
 Synthesis and characterization of bi-functional enzyme mimics
Figure 13. (a,b) Experimental Davies ENDOR spectra of a frozen DMSO:toluene (1:1) solution of 
CuIIENZm taken at  4 K ,at  an observer  position corresponding to  g≈g⊥ (B0=338 mT)  with (a) 
tπ/2=200 ns, tπ=400 ns and (b) tπ/2=48 ns, tπ=96 ns. (c) Simulation of the Ha proton contribution to 
(b) using the hyperfine data in Table 7. VH indicates the proton Larmor frequency.
Compound
Ax 
(MHz)
Ay 
(MHz)
Az 
(MHz)
CuIIENZm (Ha) 17.4 
(±0.3)
14.2 
(±0.3)
14.2 
(±0.5)
Cu(sal)2a 16.49 12.89 12.59
CuSalenc 22.8
23.62
19.38
19.45
18.43
18.64
abis-(salicylaldoximato)CuII in bis-(salicylaldoximato)NiII, b  N,N’-ethylene bis-(salicylideniminato) 
CuII in N,N’-ethylene bis-(salicylideniminato) Ni II
Table 7. Experimental proton hyperfine values of Ha compared to those of other imine-like protons 
in CuII Schiff base complexes.
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Figure 14. Matched proton HYSCORE spectrum (symmetrized) of a frozen DMSO:toluene (1:1) 
solution of CuIIENZm taken at a 4 K at a high-field position (B0=343.4 mT) . (a) Region agreeing 
with contribution of Ha. (b) Region around proton Larmor frequency.
Figure 15. X-band Mims-ENDOR spectra of a frozen DMSO:toluene solution of the CuIIENZm for 
different settings of the magnetic field (observer positions are given in the figure). All spectra are the 
sum of 30 τ  values.
The remaining  ENDOR signals  in  Figure 13b are  strongly overlapping  and stem from 
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contributions of different protons, the directly coordinated nitrogens N1 and N5 and from the 
63,65Cu hyperfine interaction (see Scheme 7 for numbering of the nitrogen nuclei). The X-band 
proton HYSCORE spectra allow an evaluation of the proton contributions. Besides the signal 
attributed to Ha, only a ridge with maximum width of ca. 4.9 MHz is found at the high-field 
observer positions near  g=g⊥ (Figure 14b). At  g≈g|| the maximum width is even lower (~2.5 
MHz).  This  agrees  with  the  X-band  Mims  ENDOR  data  (Figure  15)  and  with  the  Davies 
ENDOR spectra obtained with weak mw pulses (Figure 13a). This observation indicates that 
the largest part of the spectrum observed in Figure 13b thus stems from interactions with the 
copper nucleus and the directly coordinated nitrogens. The fact that the ENDOR signal is not 
exceeding 26 MHz, reveals that the hyperfine coupling of N1 and N5 is lower than ~50 MHz. A 
more detailed determination of the nitrogen hyperfine values is not possible based on the X-
band Davies ENDOR measurements. 
Figure  16.  W-band  ELDOR-detected  NMR spectrum of  a  frozen  DMSO:toluene  solution  of  the 
CuIIENZm taken at an observer position corresponding with g≈g⊥. 
Moreover, the Davies ENDOR spectra at the low-field settings were of very poor quality. 
In  order  to  overcome  this  problem,  W-band  ELDOR-detected  NMR  experiments  were 
undertaken, but proved to be insufficiently resolved to allow an unambiguous determination of 
the EPR parameters of the directly coupled nitrogens (Figure 16). The signal around 10 MHz is 
most  probably  due  to  the  interaction  with  N1 and/or  N3 (nuclear  frequencies  of  the  mS=1/2 
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manifold). However, since the corresponding nuclear frequency of the mS=-1/2 manifold is not 
observed, no definite attribution of the signal can be made.
Figure 17. Experimental  X-band 14N HYSCORE spectra of a frozen DMSO:toluene (1:1) solution of 
CuIIENZm taken at a 4 K at observer position (a) B0=343.4 mT (g≈g⊥,) and (b) B0=285.2 mT (g≈ g||, 
mI=-3/2). (c,d) Simulation of (a,b) using the parameters in Table 8
Figures  17a  and  17b  show  the  14N  HYSCORE  spectra  of  CuIIENZm  in  the  frozen 
DMSO:toluene solution taken at an observer position corresponding to g≈gx,y=g⊥ and g≈gz=g||,  mI=-
3/2, respectively. In the HYSCORE spectra taken at other observer positions are shown in Figure 18. 
In the HYSCORE spectrum of Figure 16a, a set of cross peaks linking the double-quantum (DQ) 
nuclear  frequencies  can  be  recognized.  These  DQ peaks  are  visible  for  all  other  magnetic  field 
settings (Figure 17), except for the  g=g||, mI=-3/2 extremum position where only the cross peaks 
linking the single-quantum frequencies are visible (Figure 17b). 
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(a)
(b)
(c)
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(d)
Figure 18. Experimental X-band HYSCORE spectra (blue) taken at observer positions (a) B0=343.4 
mT,  (b)  B0=319.6 mT,  (c)  B0=303.6 mT and (d) B0=285.2 mT overlain  with the simulation  (red) 
assuming a two-spin (S=1/2, I=1) system and using the parameters given in Table 8 of the main text.
A first indication about the spin-Hamiltonian values of the nitrogen nucleus can be obtained 
from the formula,
)3()
2
( 22 ηνν +++=± Ka IDQ (1)
whereby  a is  the hyperfine  value at  the observer  position,  νI is  the Larmor frequency, 
K=e2qQ/(4I(2I-1)h) with Q the nuclear quadrupole moment and eq the electric field gradient. K 
and the  asymmetry  parameter  η define  fully  the  principal  values  of  the  nuclear  quadrupole 
tensor P by
z
yx
z P
PP
KP
−
== η;2 (2)
Using Eq. (1), starting values can be obtained for the spectral  simulation.  Figure 17c,d 
show the simulations of the HYSCORE spectra in Figure 17a,b. The corresponding simulation 
parameters  are  given  in  Table  8.  The  small  nitrogen  hyperfine  values  indicate  that  we are 
dealing with ‘remote’ nitrogen(s),  i.e. nitrogens that are not directly bound to the copper ion. 
N2, N3 and N4 are possible candidates (see Scheme 7 for atom numbering).
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In  order  to  assign  the  14N  spin  Hamiltonian  parameters  to  the  correct  nucleus,  DFT 
computations  were  undertaken.  Since  it  is  not  a  priori clear  whether  the  chloride  anion  is 
remaining  bound to  the  CuII ion  in  solution  and whether  axial  ligation  can  occur,  different 
models  were  assumed:  [CuLCl]  (model  A),  [CuL(DMSO)]+ (model  B),  [CuL(DMSO)2]+ 
(model  C)  and [CuL(DMSO)3]+ (model  D).   At  this  stage,  an optimized  structure  of  a  fifth 
model   [CuL(DMSO)Cl]  could  not  be  obtained.  The  optimized  geometries  of  the  four 
structures are given in the as well as the computed principal g values, copper hyperfine values 
and  the  hyperfine  and  nuclear  quadrupole  data  for  the  nitrogens  N1-N5 and  protons  Ha-Hd 
(Appendix). It  should be noted that for model D, the optimized structure showed a strongly 
elongation of the bond to one of the two DMSO molecules (2.60  Å and 2.35 Å for the bond 
lengths to the axial DMSO molecules).
For all models, the magnitude of the nuclear quadrupole couplings of the remote nitrogens 
N2 and  N4 are  found  to  be  similar  and  significantly  larger  than  the  ones  of  N3 (Table  8). 
Comparison  of  these  results  with  the  experimentally  observerd  nuclear  quadrupole  data 
indicates that the cross peaks observed in the 14N HYSCORE spectra (Figures 17a,b) stem from 
N2 or N4. This is corroborated by the magnitude of the observed hyperfine interaction, which is 
in the order of 1-2 MHz (in absolute value). The observed hyperfine parameters seem to match 
the theoretical values for N2 best (Table 8). HYSCORE simulations showed that the observed 
HYSCORE spectra can stem from contributions of two nitrogen nuclei with hyperfine values 
with opposite signs as predicted theoretically for N2 and N4 (Figure 19). Furthermore, the small 
hyperfine  of  N3 leads  to  shallow  ESEEM  modulation  that  are  suppressed  by  the  strong 
modulations of N2 and N4 and do not alter the HYSCORE pattern (Figure 20).
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Figure  19.  HYSCORE simulation  (red)  assuming a  three-spin system (S=1/2,  I1=1,  I2=1) with 
A1=[1 1.9 1.25 MHz], (e2Qq/h)1=-4.5 MHz and η1=0.8 and A2=[-1 -1.7 -1.9 MHz], (e2Qq/h)2=-4.5 
MHz and η2=0.8, with the hyperfine and nuclear quadrupole tensor of the second nucleus rotated 
20o about the z axis. This simulates the contribution of a N2-like and a N4-like nitrogen (Appendix) 
and proves that the experimental data are consistent with the DFT data.
Figure 20.  HYSCORE simulation  (red) assuming a  three-spin system (S=1/2,  I1=1, I2=1) with 
A1=[-1  -1.7  -1.9  MHz],  (e2Qq/h)1=-4.5  MHz  and  η1=0.8  and  A2=[-0.03  -0.09  0.16  MHz], 
(e2Qq/h)2=-3.4 MHz and η2=0.265. α2=90o for the P2 tensor, all other Euler angles of the hyperfine 
and  nuclear  quadrupole  tensors  are  0o.  This  simulates  the  contribution  of  a  N2 and  a  N5-like 
nitrogen. The shallow modulation of the N5 nucleus hardly alters the HYSCORE patterns (compare 
with Figure 18).
51                           Enzyme Mimic to Develop Antioxidant Nanoreactors: From Synthesis to Application 
 Synthesis and characterization of bi-functional enzyme mimics
Ax 
(MHz)
Ay 
(MHz)
Az 
(MHz)
e2qQ/h
(MHz)
η Method
CuIIENZm ±1.0
(±0.2)
±1.7
(±0.2)
±1.9
(±0.1)
±4.5
(±0.1)
0.8
(±0.1)
HYSCORE
Model A, N2 -0.01 -1.0 -1.91 -5.07 0.49 DFT
Model A, N4 1.06 0.09 0.34 -5.08 0.64 DFT
Model A, N5 0.10 -0.08 -0.11 -3.42 0.27 DFT
Model B, N2 -0.02 -1.04 -1.90 -5.03 0.53 DFT
Model B, N4 2.05 1.02 1.25 -5.22 0.60 DFT
Model B, N5 0.15 -0.03 -0.07 -3.43 0.28 DFT
Table 8. Comparison between the experimental 14N spin Hamiltonian parameters derived from 
the HYSCORE spectra  of CuIIENZm in toluene:DMSO and the  14N data  computed  for two 
model structures.
Figure  21. (gz,Az)  plot  for  the  theoretical  models  A, B, C and D (triangles)  compared  to  the 
experimental  points  (asterisks)   obtained  for  CuIIENZm (1),  and CuJac (2),  CuSalen (3).  The 
values are given in Appendix (DFT) and Table 7 (EPR). The arrows indicate the parameter shifts 
upon axial ligation.
The agreement between the experimental data and the computed spin-Hamiltonian values 
for  the  different  models  is  satisfactory,  but  far  from  perfect  for  any  of  the  models. 
Nevertheless, a number of trends can already be deduced at this stage.  The comparison of the 
computed g and copper hyperfine values of models B-D shows that upon axial ligation, the gz 
value  increases  and  the  |Az|  value  decreases  (Figure  8a).  This  trend  is  also  found 
experimentally for CuII salen-type complexes. If we compare the parameters of CuSalen that 
bears  no  axial  ligands  with  those  of  the  CuJac  complex  that  has  axial  methylbenzylamine 
binding, we see a similar trend (Table 7, Figure 21). For CuJac in toluene, gz=2.190 and Az=-
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605 MHz (unpublished results), confirming this trend. The relatively large gz and small |Az| of 
the CuIIENZm seem to indicate weak (solvent) ligation. This is corroborated by the observed 
hyperfine coupling for Ha. In agreement with the experiment, the DFT computations predict a 
largely  isotropic  coupling  for  this  proton  (Appendix).  Although  the  computed  isotropic 
hyperfine  is  overestimated,  a  decrease  in  its  value  can  be  observed  upon  axial  ligation, 
suggesting that the relatively small coupling of Ha is consistent with axial copper ligation. A 
similar  decrease  is  seen  in  the  computed  hyperfine  coupling  of  N1 upon  axial  ligation 
(Appendix). Although it was impossible to determine the exact hyperfine couplings of N1 and 
N5 from the Davies-ENDOR spectra, an upper limit of 50 MHz was found. This value is below 
the computed couplings, matching the overestimation of the hyperfine values of Ha. 
For the protons Hb and Hc maximal proton hyperfine couplings of ~10 MHz and ~7 MHz 
respectively,  are  predicted  by  DFT  (Appendix).  These  values  contradict  the  experimental 
findings, where all proton couplings other than Ha are below 4.9 MHz. Interestingly, Hb and Hc 
show strong H-bonding to DMSO (Hb) or a second L ligand (Hc) in the solid state (Figure 7). 
Although it  is  clear from the above analysis  that  the solid-state structure is not retained in 
solution, it is very likely that both protons will H-bond to the surrounding solvent molecules. 
This  is  not  taken  into  account  in  the  current  DFT  models,  which  may  explain  the 
overestimation of these proton couplings.
The  last  issue,  which  should  be  addressed,  is  the  question  whether  chloride  is  still 
binding to the copper ion, or whether it  has been replaced by solvent molecules.  Figure 21 
seems  to  indicate  that  the  g and  copper  hyperfine  values  lie  more  in  the  line  of  a  2N2O 
surrounding  with  additional  axial  ligation  as  observed  for  Schiff  base  CuII complexes. 
Furthermore, the long Cu-Cl distance found for the solid-state structure of CuIIENZm strongly 
suggests detachments of the chloride ion. The DFT computations on model A predict a large 
hyperfine  coupling  on  the  35Cl  nucleus  (A  =  [56.00  1.04   -0.63]  MHz)  if  chloride  is 
equatorially binding. Unfortunately, this interaction falls within the frequency area where also 
the contributions of the N1, N5 and  63,65Cu are found in the ENDOR spectrum in Figure 13b, 
preventing  direct  verification.  The  DFT results  for  model  A are,  however,  not  in  a  better 
agreement with the experimental results than the solvated models B-D. It is interesting to note 
that, up till now, all attempts to compute an optimized geometry for [CuL(DMSO)Cl] failed 
due to detachment of the chloride anion. Although one has to be careful with interpreting this 
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failure, it may indicate that Cl- detaches when put in competition with a solvent molecule.  
3.3. SOD like activity assay
The  SOD-like  activity  of  the  complex  was  determined  by  a  modified  version  of  the 
conventional NBT test, based on Dojindo’s highly water-soluble tetrazolium salt, WST.[129] As 
WST produces  a water-soluble  formazan dye  upon reduction with a  superoxide anion,  this 
avoids the disadvantages of the conventional assay such as poor water solubility of formazan 
and  the  interaction  with  the  reduced  form  of  xanthine  oxidase.  The  IC50 value  of  our 
CuIIENZm, obtained from the plot of inhibition percentage versus complex concentration, is 
0.38µM, thus comparable with previously reported active copper SODm. (figure 22)[105a,123] 
Figure 22. WST- SOD like activty assay. Different concentration of CuIIENZm inhibiting the 
formazan formation.
The metal binding region of native SOD is known to represent the catalytic active site, 
and  in  this  respect  its  conformation  in  the  case  of  a  proposed  SOD-mimic  can  explain  its 
biological  behaviour.  Although the CuIIENZm under  study takes  on a  square-planar  mono-
copper conformation upon dissolving,  i.e.  a structure strongly different from the tetrahedral 
surrounding of the CuII ion observered in Cu,Zn-SOD and Cu,Cu-SOD, it is probably exactly 
this mono-nuclear conformation that provides an easy accessibility to the O2- anion and thus 
contributes to its high catalytic activity.
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It is interesting to note that Díaz et al.[107b]  found a conciderably larger SOD like activity 
for thiosemicarbazone copper(II) complexes having |Az| values in the range of 500-580 MHz 
than those complexes having |Az| values around 420 MHz (although the latter value is closer to 
the  Cu,Zn-SOD  case).  Jitsukawa  et  al.[102a]  studied  a  number  of  copper  complexes  with 
tripodal polypyridylamine ligands and concluded that a five-coordinated square pyramidal or 
trigonal bipyramidal structure is more favourable for a good SOD like activity than a four-
coordinated  square  planar  structure.  This  seems  to  corroborate  our  suggestion  of  DMSO 
ligation in the current CuIIENZm, based on the combined EPR and DFT models. 
3.4. Catalase like activity assay
As various SODm were reported to possess catalase-like activity,  we also tested 
CuIIENZm as a catalase-mimic. The amplex red-coupled fluorescence assay provides a simple, 
sensitive measure of catalase-like activity. LPO reacts with H2O2  in the presence of amplex red 
and a highly fluorescent product, resorufine is formed. If catalase or an antioxidant compound is 
simultaneously present, it will compete for H2O2, and thus a lower amount of resorufine will be 
formed.[130] The decay in the fluorescence signal can be related to the catalase activity. The activity 
assay clearly indicated that CuIIENZm competes with LPO in catalyzing H2O2, similar to native 
catalase (Figure 23). Since CuIIENZm plays a dual role as an SOD- and a catalase- mimic, and 
will serve for complete ROS detoxification, both with respect to superoxide radicals and related 
peroxides.
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Figure  23. Amplex red-coupled fluorescence activity assay. Kinetics of resorufine formation in the presence 
of : a) Amplex red, lacto peroxidase and H2O2, b) Amplex red, lacto peroxidase, H2O2, and catalase (1 µM), 
c) Amplex red, lacto peroxidase, H2O2, and CuIIENZm. Buffer: PBS.
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4. Encapsulation of bi-functional enzyme mimics in polymeric vesicles 
To develop antioxidant nanoreactors,  we encapsulate CuIIENZm inside polymeric  vesicles 
that  are  formed  by  self  assembly  process.  We  chose  the  copper  complex  6-(2-hydroxy-
benzaldehyde)  hydrazono-as-triazine-3,5-dione  (CuIIENZm),  for  its  bi-functional  enzyme  like 
activity.  As an amphiphilic  block copolymer  for CuIIENZm encapsulation  we used PMOXA12-
PDMS55-PMOXA12, which has already been reported as having an oxygen-permeable hydrophobic 
block.[29]
4.1. Characterization of CuIIENZm nanoreactors
It  has  been  shown  that  amphiphilic  triblock  copolymer  PMOXA-PDMS-PMOXA  self-
assemble spontaneously in dilute aqueous solutions into vesicular structures.[44,48,99] The size and shape 
of the polymeric vesicle before and after encapsulation of CuIIENZm were studied by light scattering 
(LS) and transmission electron microscopy (TEM).
4.1.1. Light scattering  
The  ratio  (ρ  =  Rg/RH)  of  the  radius  of  gyration  (Rg),  obtained  from  static  LS,  to  the 
hydrodynamic  radius  (RH),  from dynamic  LS experiments  was  0.96 for  empty vesicles,  0.93 for 
vesicles containing CuIIENZm; these values are characteristic for hollow spherical objects (vesicular 
structures). The mean RH value of 124 nm for empty vesicles decreased only slightly for CuIIENZm-
containing vesicles (110 nm), indicating that the encapsulation procedure does not affect the size and 
shape of the self-assembled objects. This fact was also observed when SOD was encapsulated by a 
different  encapsulation  procedure  inside  polymeric  vesicles  with  similar  hydrophobic/hydrophilic 
blocks, revealing that neither the encapsulation procedure nor the molar mass of the encapsulated 
compound dramatically affected the formation of polymeric vesicles containing the compound inside 
their aqueous cavities.[99]  Contrariwise, the hydrophobic and hydrophilic blocks were found to affect 
the size of the formed vesicles significantly, even when encapsulating the same compound.[29] 
4.1.2. Transmission Electron microscopy 
TEM  micrographs  of  CuIIENZm-containing  vesicles  show  spherical  objects  with 
homogeneous sizes in a range related to the RH values obtained by LS (Figure 24). In addition, TEM 
micrographs show that CuIIENZm-containing nanoreactors do not differ significantly in shape and 
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size as compared to empty vesicles, reaffirming that CuIIENZm encapsulation does not influence the 
self-assembly of PMOXA12-PDMS55-PMOXA12. 
Figure 23. TEM micrograph of CuIIENZm encapsulated in PMOXA12-PDMS55-PMOXA12 vesicles 
(room temperature, scale bar: 200 nm).
Taken together, TEM and LS results indicate that the encapsulation of antioxidant enzyme 
mimic during the auto-assembly process does not influence vesicle formation in terms of size and 
shape. 
4.1.3. Electron Paramagnetic Resonance 
A key point when CuIIENZm is encapsulated inside a carrier (liposome/polymer vesicles) is 
the preservation of its enzyme-like activity, which represents an important limiting factor that must 
be addressed. First of all, one must check whether the structure of the CuIIENZm is preserved after 
encapsulation. In principle, this can be done using CW-EPR spectroscopy. Indeed, we used this 
technique previously to characterize in detail the CuIIENZm structure. One of the big challenges in 
detecting the EPR spectra of the nanoreactors, however, is the low concentration of the vesicles. 
Figure 25a shows the EPR spectrum obtained for a frozen solution of the CuIIENZm nanoreactors. 
No signal arising from the CuII center can be discerned (the observed signal is a weak background 
signal due to the cavity). The fact that no signal is observed can be due, in principle, to one of three 
reasons: Either no CuIIENZm is included in the nanoreactors, or the overall concentration is below 
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the EPR detection limit, or a high number of CuIIENZm complexes are encapsulated per vesicle. In 
the  latter  case,  the  local  CuII concentration  will  be  very  high  (despite  the  low  overall  CuII 
concentration) and strong dipolar interactions between different CuII centers may broaden the EPR 
spectrum beyond detection. The latter option can be easily tested by recording the EPR spectrum 
after  breaking  the  vesicles  with  triton-X  (2.5  %)  (Figure  25b).  If  the  third  option  is  valid, 
CuIIENZm will be dispersed in solution and the “normal” EPR spectrum of CuIIENZm should be 
retrieved.  We indeed observed the  typical  EPR features  of  the  CuIIENZm,  as  can  be  seen by 
comparing the EPR spectrum of a frozen DMSO solution of CuIIENZm (compare Figure 25b, 25c). 
Both EPR spectra can be simulated using the following spin Hamiltonian parameters:  g||= 2.266, 
g⊥= 2.057, A||= 525 MHz, A⊥= 25 MHz (Figure 24d); only the line width differs somewhat for the 
two cases.   
Figure 25. CW-EPR spectra taken at 100 K: a) Frozen solution CuIIENZm-containing PMOXA12-
PDMS55-PMOXA12 vesicles (in PBS buffer, pH 7.4). b) Frozen solution after CuIIENZm-release 
from PMOXA12-PDMS55-PMOXA12 vesicles via addition of triton-X. c) Frozen DMSO solution of 
CuIIENZm, and d) the simulation of the EPR spectra b and c. 
These  findings  indicate  that  no  significant  structural  changes  occurred  during  the 
encapsulation/release procedure. Due to the mild self-assembly using amphiphilic copolymers, the 
encapsulation procedure affects neither the structure of the coordination sphere of CuIIENZm, nor 
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the stability of the compound. It has already been shown that the geometry of native SOD is also 
preserved after encapsulation in PMOXA-PDMS-PMOXA vesicles, but in that case only a few 
SOD molecules were encapsulated per vesicle.[99]
4.1.4. UV-Visible spectroscopy 
The UV-Vis spectra of encapsulated CuIIENZm were also compared to the free compound 
after  a  background  correction  based  on  the  absorption  spectrum  of  polymeric  vesicles.  The 
maximum of the absorption band at λ = 425 nm, corresponding to the LMCT transitions, did not 
shift after encapsulation (Figure 26), which confirms the EPR data showing that the encapsulation 
procedure affects neither the metal coordination sphere nor does it degrade the complex. The ligand 
bands appearing in  the UV-Vis region of the encapsulated  compound spectrum are,  moreover, 
similar to those of the free compound. 
Figure 26. Normalized UV-Vis spectra: a) Free CuIIENZm in PBS (straight line). b) CuIIENZm-
containing PMOXA12-PDMS55-PMOXA12 vesicles in PBS (dot-dash).
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4.2. Encapsulation efficiency of CuIIENZm nanoreactors 
The  encapsulation  efficiency  of  CuIIENZm inside  polymeric  vesicles  was  established  by 
using  the  electronic  spectra  of  CuIIENZm-containing  vesicles  compared  with  those  of  empty 
vesicles. The intense ligand to metal charge transition (LMCT) absorption band at approximately λ 
= 425 nm that is preserved after encapsulation permitted a direct estimation of the apparent value 
of CuIIENZm concentration, taking into account the total solution volume, which was determined 
to be ∼138 µM (Figure 27). As our encapsulation procedure is based on the self-assembly process 
of vesicle formation, the concentration of CuIIENZm inside of vesicles is expected to be at least as 
high as the initial CuIIENZm amount used for encapsulation. In addition, if we take into account a 
polymer membrane thickness on the order of ~15 nm,[29,42] which decreases the overall volume by a 
factor  of  0.64  to  yield  the  cavity  volume,  this  leads  to  an  even  higher  value  of  CuIIENZm 
concentration inside vesicles. 
Figure 27. UV-VIS spectra of a) empty PMOXA12-PDMS55-PMOXA12 polymeric vesicles (black), 
and  CuIIENZm-containing  PMOXA12-PDMS55-PMOXA12  vesicles in PBS (red). b)  CuIIENZm after 
background corrected with empty PMOXA12-PDMS55-PMOXA12 polymeric vesicles (black).
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In addition,  different effects, such as steric and electrostatic interactions with the polymer 
membrane,  may  favour  clustering  of  the  CuII complexes  inside  vesicles.  These  effects  of 
confinement lead to a significant  decrease in the mean free path of molecules inside the inner 
cavity, and thus explain the presence of spin-spin interactions that broadened the EPR spectrum 
beyond the detection limit. 
An encapsulation efficiency of approximately 46 % was calculated (for an initial CuIIENZm 
concentration of 300 µM). This indicates that the choice of a small molecular weight CuIIENZm 
leads  to  an  improvement  in  encapsulation  efficiency  as  compared  to  the  reported  SOD 
encapsulation efficiency of a maximum of 32 % with similar PMOXA-PDMS-PMOXA copolymer 
vesicles.[29]  However, DMSO, the solvent of choice for CuIIENZm, affects the process of vesicle 
formation. Thus, initial concentrations of CuIIENZm higher than 300 µM should be avoided from a 
technical point of view.  
4.3. Enzyme-like activity of Nanoreactors
4.3.1. SOD like activity 
The SOD-like activity of CuIIENZm nanoreactors was determined with pulse radiolysis. High 
energy  ionizing  radiation  generates  primary  radicals  (H·,  e–  (aq),  HO·)  that  are  rapidly  and 
quantitatively converted into either superoxide O2·– or its protonated form, hydroperoxyl HO2·, in 
the presence of formate.[117a] The kinetics of the decay of superoxide radicals in the presence of 
CuIIENZm-containing nanoreactors was compared to that of free  CuIIENZm and empty vesicles 
(Figure 28). The obtained half-lives (t1/2), and hence the rate of superoxide decay of  CuIIENZm 
nanoreactors, clearly indicate that the CuIIENZm-nanoreactor is active at detoxifying superoxide 
radicals in a SODm concentration-dependent manner:  higher  CuIIENZm concentration inside the 
nanoreactor leads to considerably faster decay of superoxide (Figure 29). In addition, the rapid 
decay reaction indicates high O2·– permeability of the polymeric membrane,  in good agreement 
with  previously  reported  studies  on  PMOXA-PDMS-PMOXA  copolymers  with  different 
hydrophobic/hydrophilic blocks.[25]
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Figure 28.  Pulse radiolysis assay. 1) Uncatalyzed decay observed at 280 nm for 80 µM superoxide 
produced by a 50 ns pulse of an aerated solution of 1.0 M formate and 10 mM phosphate, pH 8, in 
the  presence  of  PMOXA12-PDMS55-PMOXA12 vesicles.  2)  Superoxide  decay  catalyzed  by 
CuIIENZm (ca. 4.0 µM) encapsulated in PMOXA12-PDMS55-PMOXA12 vesicles (10 mg polymer). 
3) Superoxide decay catalyzed by free CuIIENZm (ca. 5.0 µM).
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Figure  29.  Pulse  radiolysis  assay.  Superoxide  decay  catalyzed  by  CuIIENZm encapsulated  in 
PMOXA12-PDMS55-PMOXA12 vesicles as function of the CuIIENZm concentration: 1) ca. 1.6 µM, 
2) ca. 2.7 µM, 3) ca. 4 µM. 
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4.3.2. Catalase like activity 
The catalase like activity of CuIIENZm nanoreactors was tested by the same assay as for free 
CuIIENZm in  solution  that  is  amplex  red-coupled  fluorescence  assay.   The  impermeability  of 
amplex red and LPO through the nanoreactor membrane limits the  reaction of H2O2 with LPO to 
form resorufine.  We should to take into account that simultaneous encapsulation of LPO enzyme 
and substrate  (amplex  red)  is  required  together  with  CuIIENZm inside nanoreactors  in  order  to 
analyze the resorufine formation. This represents a significant limiting factor of this assay in the 
detection of catalytic reaction of H2O2 by CuIIENZm.
However, since free CuIIENZm plays a dual role as an SOD- and a catalase- mimic, and its 
structure is not affected by the encapsulation procedure, the mimic, once inside polymeric vesicles, 
will serve for complete ROS detoxification, both with respect to superoxide radicals and related 
peroxides.
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5.  Cellular  interaction  of  nanoreactors  containing  bi-functional 
enzyme mimics 
To evaluate the efficiency of the antioxidant nanoreactors as pharmaceutical candidate, it is 
very important to understand the cellular interactions, cellular uptake, intracellular processing and 
cytotoxicity in targeted cells. In this respect, we studied the internalization and toxicity assessment 
of nanoreactors containing in THP-1 cells that play an important role in immune system.
5.1. Cellular uptake of CuIIENZm nanoreactors 
5.1.1. Flow cytometry
The quantitative uptake of nanoreactors in THP-1 cells irrespective of cellular localization was 
analyzed using flow cytometry. Flow cytometry have been used for many applications to measure 
both light scattering and fluorescence signal from nanoparticles and cells. Most flow cytometry 
measure side scatter  (SSC) intensity with a photomultiplier  and forward scatter  (FSC) intensity 
with  a  photodiode.  SSC has  been  used  to  show differences  in  the  physical  state  of  the  cell, 
including nanoparticle uptake. Forward light scatter is routinely used as a measure for cellular size 
comparisons.[131] 
After 24 h incubation with the nanoreactors, a shift in the cell population to a high sideward 
scatter signal (SSC) was observed, showing changed granularity in an SSC density plot (Figure 
30b)  compared  to  untreated  cells  (Figure.  30a).  Cells  that  became  granular  indicated  that 
nanoreactors had been taken up. Both, in cells treated with nanoreactors and in untreated cells, the 
intensity of FSC was maintained that reflects the size of a cell (Figure 30a, 30b). This indicates that 
the cells maintained their sizes during nanoreactor uptake. 
The cells incubated with nanoreactors showed an increased fluorescent signal in the FL-1 
(PE) fluorescence channel (Figure 30d) that corresponds to the internalized nanoreactors in the 
cells.  The  fluorescent  intensity  allowed  us  to  quantify  the  uptake  after  24  h  incubation  as 
approximately 11 %. No fluorescent signal was obtained for the untreated cells (Figure 30c). 
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 Figure  30. Flow cytometry analysis. Density plot of: a) THP-1 cells (control). b) THP-1 cells 
incubated  with  CuIIENZm-  and  sulforhodamine  B-containing  PMOXA12-PDMS55-PMOXA12 
vesicles for 24 h. Fluorescent intensity in FL-1 (PE) of: c) THP-1 cells. d) THP-1 cells incubated 
with CuIIENZm- and sulforhodamine B-containing PMOXA12-PDMS55-PMOXA12 vesicles after 24 
h.
5.1.2. Confocal Laser Scanning Microscopy (CSLM)
The intracellular localization of internalized nanoreactors was analyzed by Laser scanning 
confocal microscopy (CLSM). CLSM has been applied to wide range of investigations in the bio-
sciences for imaging and recently to study the cellular uptake of nanoparticles. They are equipped 
with 3-5 laser systems controlled by high-speed acousto-optic tunable  filters,  which allow very 
precise regulation of different wavelength and excitation intensities. The spectral imaging detection 
systems  further  refine  the  technique  by  enabling  the  examination  and  resolution  of  different 
fluorophores  with  overlapping  spectra  as  well  as  providing  the  ability  to  compensate  for  auto 
fluorescence.  Advanced multi colour investigation of CLSM dramatically improves the collection 
and analysis of multiple colored image obtained from complex fluorescence experiments in live-cell 
imaging.[132] 
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THP-1 cells  were incubated  with nanoreactors  containing  co-encapsulated  CuIIENZm and 
sulforhodamine B and the CLSM micrographs were analyzed in order to observe their intracellular 
localization (Figure 31). The very low auto fluorescence of THP-1 cells excited at 543 nm was 
taken into account as background. As no uptake was found after 6 h of incubation, even at a high 
dose of nanoreactors (500 µg/ml), 24 h incubation allowed us to study the cell distribution: Most of 
the  nanoreactors  were located  intracellularly  and only few were present  in  the  cell  membrane 
(Figure 31a). By staining the cell membrane with a second dye, Deep Red, which emits at another 
wavelength  value  (Figure  31b),  we were  able  to  distinguish  the  extracellular  and  intracellular 
region  of  the cells,  and  thus  localize  the  nanoreactors  more  precisely.  For  more  detail  on the 
internalization  of  nanoreactors,  the  cellular  nucleus  was  stained  with  a  third  dye,  DAPI. 
Nanoreactors were found to be present in the intracellular  regions of the cells (Figure 31d), in 
agreement with the above analysis  of CuIIENZm- and sulforhodamine B-containing nanoreactor 
micrographs.  However,  no CuIIENZm-containing  nanoreactors  were found to  be present  in  the 
nucleus (Figure 31c).  
Figure  31.  Confocal  images  of THP-1 cells  after  24 h incubation  with sulforhodamine  B and 
CuIIENZm  co-encapsulated  inside  PMOXA12-PDMS55-PMOXA12  vesicles. a)  Internalized 
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CuIIENZm- and sulforhodamine B-containing vesicles, shown in the red channel. b) THP-1 cells 
membrane stained with Deep Red, shown in the green channel. c) THP-1 cell nucleus stained with 
DAPI, shown in the blue channel; d) Overlay of the micrographs from the red, green, and blue 
channels.
We observed only a limited number of cells containing internalized nanoreactors after 24 h 
incubation.  This increased significantly after  48 h incubation (Figure 32). The number of cells 
containing nanoreactors as well as the number of internalized nanoreactors increased after 48 h 
incubation. This indicates the slower and time dependant uptake rate of nanoreactors containing 
CuIIENZm in THP-1 cells.
Figure  32.  Confocal  images  of  THP-1 cells  after  48 h incubation  with sulforhodamine  B and 
CuIIENZm  co-encapsulated  inside  PMOXA12-PDMS55-PMOXA12  vesicles. a)  Internalized 
CuIIENZm- and sulforhodamine B-containing vesicles, shown in the red channel. b) THP-1 cells 
membrane stained with Deep Red, shown in the green channel. c) Overlay of the micrographs from 
the red and green channels.
5.1.3. TEM 
The intracellular localization of CuIIENZm-containing nanoreactors was visualized by TEM, 
which provides a higher resolution than CLSM. After 24 h cell incubation with nanoreactors, TEM 
images of THP-1 cells show that the nanoreactors were present in intracellular compartments that 
resemble endosomes (Figure 33a) and in cytoplasm (Figure 33b). The presence of nanoreactors in 
the  endosome  like  intracellular  compartments  suggested  an  endocytic  uptake.  However  it  is 
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difficult to clearly differentiate polymeric vesicles from vacuoles and vesicular structures of the 
cell due to similarity in shape and size. Therefore, we analyzed the membrane structure in greater 
detail.  Polymeric  vesicles  show  alterations  to  their  membranes  in  the  form  of  deformational 
shrinkage,  in  contrast  to  vesicular  structures  of the cell.  The image suggests  that  nanoreactors 
escaped the endosomes (Figure 33b, 33c) presumably due to the interaction of polymers with lipid 
membrane. 
The number of intact nanoreactors present in the cytoplasm was significantly increased after 
48 h incubation (Figure 34). This is in agreement with other studies that reported a time-dependent 
release of copolymer systems from endosomes.[133] No uptake of nanoreactors was recognized in the 
mitochondria or the nucleus, in agreement with other studies on polymer nanoparticles of similar 
sizes.[134]  In the case of PLGA polymeric particles, uptake into the nucleus was reported, but no 
explanation for this response has been given.[135]
Figure 33. TEM images of THP1 cells incubated for 24 h with CuIIENZm-containing PMOXA12-
PDMS55-PMOXA12 vesicles: a) Intracellular area, as an endosome-like compartment; b) Cytoplasm 
area containing shrunken polymeric vesicles (indicated by arrows); c) Zoom of shrunken polymeric 
vesicles in the cytoplasm (indicated by arrows).
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Figure 34. TEM images of THP1 cells incubated for 48 h with CuIIENZm-containing PMOXA12-
PDMS55-PMOXA12 vesicles:  a)  Cytoplasm  area  containing  polymeric  vesicles;  b)  Zoom  of 
polymeric vesicles in the cytoplasm.
5.2. Cytotoxicity of CuIIENZm nanoreactors
The cytotoxicity of CuIIENZm-containing nanoreactors was assessed with a colorimetric assay 
based  on  the  formation  of  a  colored  formazan  product  when  MTS is  biologically  reduced  by 
metabolically active cells. As the amount of formazan relates to the metabolic state of the cells and 
cell  viability,[136]  the  MTS assay  allows  an  assessment  of  the  toxicity  of  CuIIENZm-containing 
nanoreactors in comparison to empty polymer vesicles, or to free CuIIENZm. While free CuIIENZm 
(20 μM) inhibited the proliferation of THP-1 cells after 24 h, and cell viability of approximately 79 
% was shown (Figure 35a), a similar concentration of CuIIENZm inside the nanoreactors exhibited 
significantly higher viability, up to 98 % (Figure 35b). This clearly indicates that encapsulation in 
polymeric  vesicles prevents toxicity due to free CuIIENZm, in addition to providing a shielding 
effect  that  protects  the compound from degradation.  Moreover,  empty polymer  vesicles  did not 
show a toxic effect in the cells after 24 h incubation, even at a high dose of polymer (300 µg/ml) 
(Figure 35c). 
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Figure 35. MTS assay. THP-1 cell viability after incubation with different concentrations of: a) 
free  CuIIENZm.  b)  Estimated  concentration  of  CuIIENZm inside  PMOXA12-PDMS55-PMOXA12 
vesicles. c) Empty PMOXA12-PDMS55-PMOXA12 vesicles. White bars: incubation time 24 h; grey 
bars: incubation time 48 h.
Increased  viability  was  observed  with  polymer  vesicles/nanoreactors  after  a  prolonged 
incubation time of 48 h, depending on the concentration of polymeric vesicles. This is presumably 
due to the reaction of MTS with the O2·– that is produced by NADPH oxidase activity. This activity 
is sustained and relates to the prolonged and time-dependent uptake of nanoreactors/vesicles.[137,138] 
Increased viability of cells when incubated with different PMOXA-PDMS-PMOXA-based vesicles 
has already been reported, but not interdependent with vesicle concentration.[45]
LDH assay
Another approach to assess nanoreactor cytotoxicity was based on LDH assay that allows an 
estimation of membrane integrity by cytosolic enzyme release from cells.[139] The LDH assay was 
performed for THP-1 cells incubated with CuIIENZm nanoreactors, and compared to cells treated 
with empty vesicles or with free CuIIENZm (Figure 36). Cells treated with free CuIIENZm (20 μM) 
showed a release of less than 5 % LDH, as expected for a low molecular weight compound known 
to diffuse through the cell  membrane without  affecting membrane integrity.[140]  A high dose of 
empty vesicles or nanoreactors (300 µg/ml polymer concentration) showed an increase in LDH of 
up to 24 %. However, the half-maximum inhibitory concentration (IC50) was not reached after 24 h 
incubation, indicating that CuIIENZm-containing nanoreactors are not toxic at doses in the range of 
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100-300 µg/ml polymer concentration. In addition, these high doses are not expected to accumulate 
in biologically relevant conditions.
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Figure 36. LDH assay. The cytotoxicity of different concentration of: a) CuIISODm, b) CuIISODm 
nanoreactors (grey bars) and empty vesicles (black bars), respectively.
5.3. In vitro activity of CuIIENZm nanoreactors
An essential  point  was  to  prove  the  in-vitro activity  of  CuIIENZm-nanoreactors.  In  this 
respect, we generated oxidative stress on THP-1 cells and analyzed the protective effect against 
paraquat-mediated cytotoxicity. Several studies suggested ROS involvement in the toxicity induced 
by paraquat, thereby enhancing cell death.[141-143] While THP-1 cells treated with 2 mM paraquat for 
24 h exhibited approximately 48 % loss of viability, cells first treated with CuIIENZm nanoreactors 
for 24 h, and subsequently with paraquat for another 24 h showed a significant decrease in the loss 
of viability (maximum 23 %) (Figure 37). This indicates that CuIIENZm nanoreactors were active 
inside the cells and thus provided good protection against oxidative stress. 
The  increased  population  of  cells  containing  nanoreactors  after  a  48  h  incubation,  as 
compared to a 24 h incubation (see CLSM micrographs), and the location, mainly in the cytoplasm 
(see TEM images),  explain the protective effect  of nanoreactors.  Moreover,  even if  the mimic 
exhibits  lower activity as compared to  native enzymes,  its  higher concentration inside vesicles 
supports the protective effect we observed. We must also mention that nanoreactors and paraquat 
simultaneously co-incubated with THP-1 cells for 24 h provided a lower protective effect. This is 
assumed to  be due to  rapid paraquat  uptake by cells,  which induced oxidative  stress and then 
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cytotoxicity that could not be prevented by the presence of CuIIENZm nanoreactors, as they were 
internalized more slowly compared to paraquat.  
The fact that CuIIENZm is a dual mimic of SOD and catalase allows in situ detoxification of 
both superoxide radicals and related H2O2, and in this way a system is obtained that does not have 
the generation of ROS as a side effect. However, as our nanoreactor has a membrane which is not 
permeable to H2O2, its main role is to detoxify O2·– and the H2O2  product that develops inside the 
vesicles.  
Figure  37.   Flow cytometry  analysis:  in-vitro antioxidant  activity  of  CuIIENZm nanoreactors. 
Viability of THP-1 cells after 24 h incubation with control, nanoreactors, and paraquat. 1) Viability 
of untreated control cells considered as 100 %. 2) Viability of cells after paraquat exposure. 3) 
Viability  of  cells  pretreated  with  CuIIENZm nanoreactors  for  24 h and sequentially  treated  by 
paraquat for additional 24 h.
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6. General Conclusion and Outlook 
We propose here a new concept of enzyme mimics containing nanoreactors in 4 different 
steps.
I. Structure-Activity relationship analysis to obtain high active SODm model
We have demonstrated the first successful global structure–activity relationship based 
on statistical analysis of all classes of copper complexes proposed to have a SOD like activity. 
We took into account all copper-based SODm with electronic and EPR parameters that have 
been  published,  and  established  the  specificity  of  the  geometry  around  the  metal  as  an 
essential criterion for a highly active SODm. The model we obtained for highly active SODm 
is that a slightly distorted square planar geometry seems to favour high catalytic activity for 4-
coordination sphere in agreement with the geometry of native SOD[144]  and for 5-coordinated 
SODm is square pyramidal, with a slightly distorted basal plane.
II. Synthesis and characterization of a high active CuIIENZm 
We have successfully synthesized  a  highly active  enzyme mimics  (CuIIENZm).  The 
detailed  structure  of  CuIIENZm in  solid  state  as  well  as  in  solution  was studied  by X-ray 
crystallography and Electron paramagnetic resonance. CuIIENZm is shown to a change from a 
di-copper complex in the solid state to a mono-copper complex in solution and obtained a 
square-planar  conformation.  Upon  a  weak  ligation  of  the  solvent  molecule,  it  preserves  a 
pyramidal  structure,  as established  by the combined pulsed EPR and DFT analysis. In this 
respect,  the flexible  solvent  coordination site of CuIIENZm can be related to its  high SOD 
activity.  The presence of a solvent molecule in an equatorial position may be related to the 
labile bridge present in native SOD between Cu and Zn centers, which breaks to allow the 
geometric  change  during  the  catalytic  reaction.[144]  Therefore,  the  structural  geometry  of 
CuIIENZm can be related to the obtained structural model for highly active SODm based on 
SAR analysis.
III. Encapsulation of CuIIENZm in polymeric nanoreactors
We developed  a  robust  antioxidant  nanoreactor  based  on  the  encapsulation  of  highly 
active  CuIIENZm that permits higher encapsulation efficiency as compared to a nanoreactor 
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containing  the  enzymes  themselves.  This  is  attributable  to  intrinsic  properties  of  the 
CuIIENZm, such as improved solubility and elimination of the severe constraints required to 
avoid  enzyme  denaturation.  CuIIENZm  was  encapsulated  inside  the  aqueous  cavity  of 
polymeric  nanovesicles  generated  by  the  self-assembly  of  PMOXA-PDMS-PMOXA 
amphiphilic  copolymers.  The  mild,  structure-preserving  procedure  used  to  encapsulate 
CuIIENZm had no affect on the size/shape of the vesicles, as indicated by light scattering and 
TEM, or on the metal-coordination sphere that  served as a center  for catalytic  activity,  as 
demonstrated by EPR and UV-Vis spectroscopy. 
IV. Cellular interaction of CuIIENZm containing nanoreactors
The cellular  interaction of CuIIENZm containing nanoreactors was studied with THP-1 
cells such as internalization, cytotoxicity, and  in vitro activity. Approximately 11 % of cells 
contained internalized nanoreactors after 24 h incubation even without a functionalized vesicle 
surface  to  support  a  targeted  approach.  The  antioxidant  nanoreactors  showed  minimal 
cytotoxicity after 24 h incubation compared to free CuIIENZm. The population of THP-1 cells 
containing the antioxidant nanoreactors was significantly increased after 48 h incubation, and a 
protective antioxidant effect (23 %) against oxidative stress by paraquat was established. As 
CuIIENZm is both a mimic of SOD and of catalase, it serves to detoxify superoxide radicals 
and related H2O2 inside vesicles, preventing the generation of ROS as a side effect. The well 
pronounced antioxidant activity of nanoreactors in cells clearly points to a unique method to 
provide  enzyme-  mimics  based  antioxidant  therapy,  whereby  encapsulating  mimics  in 
polymeric  nanoreactors  avoids  mimic  degradation  within  biological  compartments  and 
simultaneously  allows  CuIIENZm to  act  in  situ when  concentrated  inside  nanometer-range 
polymer cavities. 
Compared with conventional drug nanocarriers made of liposomes or polymers, our system 
is more stable and combines the advantages of a polymer shield with an in situ active antioxidant 
compound.  This  type  of  nanoreactors  is  proposed  to  function  as  versatile  antioxidants,  able  to 
escape  the  immune  system,  for  medical  applications.  Development  of  this  simple,  robust 
antioxidant nanoreactor represents a new direction in fighting oxidative stress efficiently. However 
it is very important to  investigate further the interaction of nanoreactors with biological systems 
such as cells, tissues, animal models in detail to understand the intracellular fate of nanoreactors, 
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such as internalization kinetics, intracellular trafficking, biodistribution and biocompatibility that 
are important to design more efficient nanoreactors for therapeutic applications.
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7. Experimental Section
Materials
6-(2-hydroxy-benzaldehyde) hydrazono-as-triazine-3,5-dione (L) was received from Dr. C. 
Cristescu, National Institute for Chemical and Pharmaceutical  Research, Bucharest.  All reagents 
and solvents  were purchased from Aldrich or  Fluka with the  highest  purity  grade and used as 
received. Cu/Zn-SOD  from  bovine  erythrocytes,  Lacto  peroxidase  (LPO)  from  bovine  milk, 
Catalase from bovine liver (Sigma Aldrich),  and the 6-(2-hydroxy-benzaldehyde)  hydrazono-as-
triazine-3,5-dione  based  Cu  (II)  complex  (CuIIENZm)  were  used  without  further  modification. 
RMPI-1640 cell  culture  medium (GIBCO),  fetal  calf  serum (FCS),  penicillin  and streptomycin 
(Sigma  Aldrich),  as  well  as  dimethylsulfoxide  (Aldrich),  chloroform  (99.8  %;  Fluka), 
paraformaldehyde (Fluka), glutaraldehyde (Fluka), osmium tetroxide (Fluka), phosphate buffered 
saline (PBS) , hydrogen peroxide 30% (w/w) and sodium formate (Sigma-Aldrich) were used as 
received.  10-acetyl-3,7-dihydroxyphenoxazine (amplex red),  Sulforhodamine B, CellmaskTM Deep 
Red, 4',6-diamidino-2-phenylindole (DAPI) and propidium iodide were purchased from Invitrogen. 
Polycarbonate membrane filters (Millipore), and sepharose 2B (Sigma Aldrich) were used. 
Preparation of CuIIENZm
Metal complexation of  L was performed in a modified approach of an earlier procedure.
[119] L (1mM) was dissolved under stirring in 20 ml NaOH (0.05mM) at 40°C and the pH was 
adjusted to 7.5 with NaOH (1M). A solution of CuCl2 ⋅2H2O (1mM) in 5ml of milli-Q water 
was added slowly drop wise for 20-30 minutes at 40°C. The mixture was cooled to 4°C and 
stirred continuously for 1 hour under atmospheric  pressure,  forming a green precipitate.  The 
precipitate was filtered, washed successively with hot water, ethanol and acetone and was dried. 
The  powder  was  re-crystallised  in  DMSO  by  slow  evaporation  method  and  formed  small 
crystals after more than 2 months at room temperature.
UV/Vis absorption spectroscopy
UV-VIS spectra were recorded with a Perkin Elmer Lambda 35 UV/VIS spectrometer in 
0.5 ml silica glass cells between 200 nm and 950 nm, at 25ºC. CuIIENZm and free L solutions 
(1mM) were prepared in DMSO. 
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IR spectroscopy
IR  spectra  of  the  powders  of  CuIIENZm were  measured  with  a  Shimadzu  FTIR  8400S 
spectrometer from 400 cm-1 to 4000 cm-1 with a resolution of 1 cm-1. 
Continuous-wave (CW) EPR
X-band  CW-EPR  measurements  were  performed  on  a  Bruker  ESP  300E  instrument, 
equipped with a liquid Helium cryostat (Oxford Inc.), at a microwave (mw) frequency of about 
9.43 GHz. A mw power  of 20 mW, a  modulation  frequency of 100 kHz and a modulation 
amplitude of 0.5 mT were applied. All spectra were taken at 100 K. The EasySpin program was 
utilized  to  simulate  the  CW-EPR  spectra.[145] The  CuIIENZm complex  was  dissolved  in 
DMSO:toluene (1:1 to 1:4) mixtures.  Addition of toluene was needed to obtain a good glass 
upon freezing.
Pulsed EPR
The X-band (9.76 GHz) pulsed EPR experiments were performed on a Bruker ESP380E 
spectrometer, equipped with a helium-gas flow cryostat (Oxford Inc.). The measurements were 
done at 4K, with a repetition rate of 1 kHz. 
The  standard  HYSCORE (hyperfine  sublevel  correlation)  experiments  were  performed 
using the π/2 – τ - π/2 - t1 – π - t2 - π/2 – τ  - echo sequence of pulses with tπ/2 = 16 ns and tπ = 16 
ns.  The  time  intervals  t1 and  t2 were  varied  in  steps  of  16  ns.  The  matched  HYSCORE 
experiments were performed using the π/2 – τ – HTA – t1 – π – t2 – HTA – τ – echo sequence 
with tπ/2 = 16 ns, tπ = 16 ns and τ =152 ns. The length of the high-turning-angle (HTA) pulse was 
taken to be 40 ns with ν1=15.625 MHz to selectively enhance the proton signals. In order to get 
rid of unwanted echoes, an eight-step phase cycle was applied for all HYSCORE experiments. 
The  time-domain  HYSCORE spectra  were baseline  corrected  with  a  third-order  polynomial, 
apodized with a Hamming window and zero filled. The absolute-value spectra, obtained by two-
dimensional Fourier transformation, were added for the different  τ values to reduce the blind-
spot effect. The HYSCORE spectra were simulated using a program developed at ETH.[146] 
The Davies ENDOR (electron nuclear double resonance) experiments were performed using 
the mw pulse sequence π – T – π/2 – τ – π – τ – echo, whereby a pi radio-frequency (rf) pulse is 
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applied during time T. The parameters used were the following: tπ = 96 (400) ns, tπ/2 = 48 (200) 
ns, T = 31µs, trf = 29 μs. 
The Mims ENDOR experiments were performed with the mw pulse sequence π/2 – τ – π/2 – 
T – π/2 – τ - echo. The parameters used were:  tπ/2 = 16 ns,  T = 30µs,  trf = 28 μs. The spectra 
were  recorded  and  added  for  15  τ values  from  104  ns  to  216  ns,  in  order  to  avoid  τ - 
dependent blind-spots.
The W-band (94 GHz) pulse EPR experiments were performed on a Bruker ELEXSYS E680 
spectrometer equipped with a helium-gas flow cryostat.   All measurements were done at 5 K 
using a repetition rate of 200 Hz. 
W-band ESE (electron spin echo)-detected EPR experiments were performed using the pi/2 – 
τ – pi – τ – echo sequence with tπ/2=148 ns, tπ =296 ns and τ = 800 ns.
W-band  ELDOR-detected  NMR  experiments  were  performed  using  the  mw  sequence: 
(HTA)mw2 - T -  (π/2)mw1 – τ – (π)mw1 – τ – echo sequence, with tHTA = 20 µs, tπ/2=148 ns, tπ= 296 
ns, T=1 µs and τ = 800 ns. The second microwave frequency, mw2, was varied in steps of 120 
kHz in the range mw1 ± 60 MHz.
Preparation of CuIIENZm-containing polymer vesicles 
 The synthesis and characterization of PMOXA12-PDMS55-PMOXA12  copolymer has been 
reported elsewhere.[37]  Vesicles of PMOXA12-PDMS55-PMOXA12  in PBS at pH 7.2 were generated 
by the film rehydration method. A solution of polymer (5 mg/ml) dissolved in 1 ml of chloroform 
was slowly evaporated in a rotary vacuum evaporator at 40 °C at 50 rpm and 260 mbar vacuum 
(Buchi Rota vapor R-124 with vacuum controller B-721, Buchi Switzerland) until a film formed on 
the inside of the flask. The film was dried under vacuum (0.3 mbar) for at least four hours, then a 
PBS solution (1 ml) and a solution of CuIIENZm (300 μM/ml) were added and stirred for 48 h at 
room temperature. The mixture was extruded once with a polycarbonate membrane filter (pore size 
400 nm), and 21 times with a polycarbonate membrane filter (pore size 200 nm) to decrease the 
size-polydispersity of the vesicles. Subsequently,  the extruded solution was purified by SEC on 
sepharose 2B (10  × 300 mm) to remove the non-encapsulated CuIIENZm. Empty vesicles were 
generated under similar conditions, without addition of CuIIENZm solution.
Light scattering (LS)
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Dynamic (DLS) and static (SLS) light-scattering experiments to determine the sizes and size 
distribution  of  empty  and  CuIIENZm-containing  vesicles were  performed  on  a  ALV  (Langen, 
Germany) goniometer, equipped with an ALV He-Ne laser (λ = 632.8 nm). Empty and CuIIENZm-
containing vesicles were prepared by serial dilution to polymer concentrations ranging from 3.33 to 
0.1 mg/ml. Light scattering was measured in 10-mm cylindrical quartz cells at angles of 30–150 ° at 
293 K. The data for DLS were analyzed using a Williams-Watts function. The size polydispersity of 
the vesicles was determined according to the literature.[147]
Transmission electron microscopy (TEM)
The solutions of polymeric vesicles with and without CuIIENZm were negatively stained 
with 2% uranyl acetate, then mounted on a carbon-coated copper grid, and dried. The samples were 
analyzed with a Philips Morgagni 268D transmission electron microscope at 293 K.
Electron paramagnetic resonance (EPR)
An aqueous solution of CuIIENZm nanoreactors was prepared and measured with EPR (PBS 
buffer, pH 7.4). Next, a solution of 5% triton X was added (at a 1:1 (v/v) ratio) and the mixture, 
kept for 48 h at room temperature,  was then measured by EPR. X-band CW-EPR spectra were 
obtained with a Bruker ESP 300E spectrometer, equipped with a liquid Helium cryostat (Oxford 
Inc.).  The EPR spectra  were recorded at  100 K.  A microwave power of 5  mW, a modulation 
frequency of 100 kHz and modulation amplitude of 0.5 mT were applied. Each spectrum was the 
accumulation of 50 scans. The Easy Spin tool for Matlab was utilized to simulate the CW-EPR 
spectra.
Encapsulation efficiency of CuIIENZm nanoreactors
Solutions of CuIIENZm-containing vesicles were measured by detecting light absorption at λ 
= 425 nm (UV/Vis absorption spectrometer:  Perkin Elmer,  Lambda 35 spectrophotometer).  The 
concentration of CuIIENZm inside vesicles was obtained with a standard calibration curve in the 
range of 10-400 μM, after  background correction of the polymer  absorption.  The encapsulation 
efficiency was calculated as the ratio between encapsulated CuIIENZm concentration and the initial 
concentration of CuIIENZm.
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SOD mimicking activity assay
To measure the activity of CuIIENZm nanoreactors, pulse radiolysis was used with a 2 MeV 
Febetron 705 accelerator (Titan Systems Corp., San Leandro, CA, USA) at 20 °C in a 1 cm quartz 
cell. The oxygenated sodium formate (1 M) solution at pH 8.0 was irradiated to generate O2•– in the 
environment of CuIIENZm nanoreactors. SOD-like activity was calculated from rates of decay of 
O2•–, measured at λ = 280 nm, in the presence/absence of CuIIENZm. 
Catalase mimicking activity assay
The  catalase-like  activity  in  solution  was  assessed  by  using  an  amplex  red-coupled 
fluorescence assay. The solutions containing 50 µL of LPO (0.5 µM) and 30 µL of amplex red (10 
µM) under three different circumstances, with catalase, without catalase, and with CuIIENZm, were 
mixed in a quartz cuvette and the fluorescence intensity of resorufin (λex =530 nm, λem = 580 nm) 
was followed after the addition of 45 µL of H2O2 (16 µM). The fluorescence intensity was recorded 
in a PerkinElmer LS55 fluorescence spectrometer (Waltham, Massachusetts, USA) in the kinetic 
mode at ambient temperature. 
Cell culture
THP-1 cells were kept in RPMI-1640 growth medium supplemented with 10% fetal calf 
serum, 1% penicillin (10,000 units/ml) and streptomycin (10,000 µg/ml), 2 mM L-glutamine and 1 
mM pyruvate.  Cells were grown in a humidified incubator (HERA Cell 150, Thermo scientific, 
Germany) at 37 °C in a 5% CO2 atmosphere. 
Cellular uptake of CuIIENZm nanoreactors
Cellular  uptake of CuIIENZm nanoreactors  was established  by flow cytometry,  confocal 
laser scanning microscopy (CLSM) and transmission electron microscopy (TEM). CuIIENZm and 
sulforhodamine B were simultaneously encapsulated during the formation of vesicles, as mentioned 
above. THP-1 cells were cultured in a 6-well plate at different densities of cells per well  (2 × 105 
for CLSM and flow cytometry analysis, and  1  × 106 for TEM) in RPMI medium and incubated 
with a nanoreactor solution containing co-encapsulated sulforhodamine B and CuIIENZm, for 24 h 
at 37 °C in a humidified CO2 incubator. 
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Flow cytometry analysis
Cells  treated  with  a  solution  of  co-encapsulated  CuIIENZm-  and  sulforhodamine  B-
containing nanoreactors prepared as above were washed with PBS to deplete the free nanoreactors 
and analyzed for the quantitative uptake of CuIIENZm nanoreactors with a flow cytometry set-up 
(CYAN, BD biosciences). A total of 20,000 events were analyzed for each condition.
Confocal laser scanning microscopy
Cells  pre-treated  with  a  solution  of  nanoreactors  co-encapsulated  with  CuIIENZm-  and 
sulforhodamine B were incubated at 37 °C with freshly prepared Deep Red (cellmaskTM) plasma 
membrane stain (5 µg/ml) for 5 min, followed by DAPI nucleic acid stain (300 nM) for 5 min. They 
were then washed with PBS buffer and visualized with a confocal laser scanning microscope (Carl 
Zeiss LSM510) equipped with 63× water emulsion lens (Olympus), and three lasers (λi = 405, 543, 
and 633 nm). The measurements were performed in multi-track mode, and the intensity of each 
fluorescent dye was adjusted individually: sulforhodamine B excited at 543 nm in channel 3, Deep 
Red excited at 633 nm in channel 2, and DAPI nuclear stain excited at 405 nm in channel 1. The 
images  containing  the  superposition  of  all  three  dyes  were  processed  using  Carl  Zeiss  LSM 
software (version 3.99).
Transmission electron microscopy (TEM)
THP-1  cells  pre-incubated  with  a  nanoreactor  solution  containing  co-encapsulated 
sulforhodamine B and CuIIENZm were fixed with a solution of 3% paraformaldehyde in PBS, and 
0.5% glutaraldehyde in PBS containing 1.5% saccharose (pH 7.3), and then post-fixed in 0.5% 
aqueous osmium tetroxide. The samples were then dehydrated in a graded series of ethanol and 
block-stained in 6% of uranyl acetate and embedded in LR white resin. Ultra thin sections were 
contrasted with 0.3% lead citrate and imaged using a Philips Morgagni 268D.
Cytotoxicity assay of CuIIENZm nanoreactors
The  cytotoxicity  of  the  CuIIENZm-containing  nanoreactors  was  evaluated  based  on 
mitochondrial  function  and  membrane  integrity  of  THP-1  cells  by  using  the  MTS-(3-(4,5-
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dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium)  and  a 
lactose dehydrogenase (LDH) assay.
MTS assay 
Cells were cultured in a 96-well plate at a density of approximately 2 × 104  cells per well, 
and incubated with 100 μl of RMPI growth medium/well for 24 h. A series of empty vesicles, free 
CuIIENZm and CuIIENZm nanoreactors at different concentrations was added to different wells and 
incubated  with cells  for  a  period  of  time  (24 and 48 h ).  Subsequently,  20 μl  of  CellTiter  96 
Aqueous One Solution Cell Proliferation Assay (MTS) reagent (Promega) was added to each well 
and then incubated for 2 h. The absorbance of each well mixture was measured with a Spectromax 
M5e microplate reader (Molecular Devices) at  λ = 490 nm. Cell viability (%) was calculated as 
[Asample  /  Acontrol]  × 100.  Errors  are  based  on  the  standard  deviation  of  three  independent 
measurements.
LDH assay
The cytotoxicity  of  CuIIENZm nanoreactors  was  assessed by  LDH leakage  from THP-1 
cells,  with a CytoTOX 96 non-radioactive cytotoxicity assay (Promega).  Cells were cultured in a 
96-well plate at a density of approximately 2  × 104  cells per well, and incubated with 100 μl of 
RMPI growth medium/well for 24 h. Cells suspensions were then centrifuged at 250 RCF for 5 min, 
and 50 µl of supernatant were transferred from each well to a new plate. Substrate solution (50 µl) 
was added and incubated for 30 min. After incubation, a stop solution (50  µl) was added to the 
wells,  and  the  mixture  was  immediately  measured  with  a  Spectromax  M5e  microplate  reader 
(Molecular Devices), at  λ = 490 nm. Control experiments were performed both for the maximum 
LDH  release  after  cell  lysis  with  10  %  (v/v)  Triton®X-100,  and  for  the   LDH  released 
spontaneously from intact cells. Cell culture medium with and without CuIIENZm nanoreactors was 
taken into account  as background. Cytotoxicity of the samples  was calculated according to  the 
manufacturer’s protocol.
In-vitro activity of CuIIENZm nanoreactors 
To  determine  the  antioxidant  activity  of  CuIIENZm  nanoreactors,  oxidative  stress  was 
induced by paraquat and analyzed by flow cytometry (CYAN, BD Biosciences).  THP-1 cells at a 
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density of 1  × 105  plated in a 6-well transparent microplate were first incubated with CuIIENZm 
nanoreactors (500 µg/ml) for 24 h, and subsequently with paraquat (2 mM) for further 24 h  at 37 
°C in a 5% CO2 atmosphere. Cells were washed with PBS buffer and stained with propidium iodide 
(PI,  50  µg/ml)  to  determine  cell  viability.   A  total  of  10,000  events  were  analyzed  for  each 
condition.
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8. Appendix
A1. Optimized structures of models used in DFT computations
MODEL A, [CuLCl] - Optimized structure
Coordinates from ORCA-job
O      -7.190519     -1.471015     -0.137343
O      -5.302588      2.729449     -0.020150
O       0.018234     -1.426313     -0.107058
C       3.245777      1.208592     -0.020664
C       3.417168     -0.193990     -0.049435
C       2.328658     -1.048548     -0.078346
C       0.995596     -0.553066     -0.079982
C       0.823049      0.875484     -0.050613
C       1.965324      1.723580     -0.021379
C      -0.456146      1.505263     -0.047137
N      -1.589274      0.852058     -0.073340
N      -2.767943      1.554769     -0.062958
C      -3.895898      0.814194     -0.078360
N      -3.779328     -0.489297     -0.112237
Cu     -1.856326     -1.116730     -0.125525
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Cl     -2.434933     -3.325606     -0.210093
N      -4.914501     -1.252004     -0.135411
C      -6.196085     -0.766785     -0.118828
N      -6.265906      0.637941     -0.078329
C      -5.204242      1.515436     -0.055667
H      -0.490736      2.593897     -0.020410
H      -2.793093      2.566427     -0.010891
H      -4.738692     -2.249959     -0.162157
H      -7.203433      1.034658     -0.064357
H       4.108474      1.869469      0.001773
H       4.422190     -0.612934     -0.048928
H       2.462277     -2.123597     -0.100152
H       1.805893      2.800626      0.000976
MODEL B, [CuL(DMSO)]+ - Optimized structure
Coordinates from ORCA-job
O      -7.423745     -0.712978     -0.085716
O      -5.189028      3.307449     -0.354847
O      -0.282016     -1.310999      0.028527
C       3.200006      0.975020     -0.134864
C       3.228147     -0.432540     -0.023509
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C       2.056833     -1.170207      0.027996
C       0.784191     -0.543628     -0.028506
C       0.754741      0.891165     -0.142954
C       1.978512      1.615613     -0.192590
C      -0.451438      1.653496     -0.211359
N      -1.647329      1.125143     -0.181160
N      -2.758393      1.926941     -0.252166
C      -3.947284      1.286554     -0.208652
N      -3.943513     -0.019548     -0.114125
Cu     -2.093602     -0.780494     -0.045717
O      -2.811240     -2.592435      0.111539
N      -5.137127     -0.685968     -0.079183
C      -6.375284     -0.094936     -0.124354
N      -6.324290      1.307203     -0.221970
C      -5.192629      2.092487     -0.270991
H      -0.368842      2.740040     -0.294496
H      -2.695332      2.937467     -0.296978
H      -5.055351     -1.695192     -0.001262
H      -7.225074      1.780580     -0.258322
H       4.125276      1.543896     -0.174542
H       4.184830     -0.950229      0.022648
H       2.079694     -2.254133      0.113331
H       1.931177      2.700023     -0.278724
S      -1.897349     -3.862090     -0.121672
C      -1.224092     -4.252141      1.516143
C      -3.122626     -5.185521     -0.278487
H      -2.042148     -4.312848      2.240872
H      -0.529930     -3.445100      1.765664
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H      -0.688101     -5.204549      1.439811
H      -3.798635     -5.157180      0.581640
H      -2.579004     -6.135206     -0.326353
H      -3.663002     -5.014153     -1.213672
MODEL C, [CuL(DMSO)2]+ - Optimized structure 
Coordinates from ORCA-job
O      -2.302400     -0.876937     -3.072378
S      -1.246324     -0.941387     -4.237406
C      -2.286826     -1.011216     -5.718045
C      -0.628318     -2.646061     -4.222681
H      -2.782614     -0.040532     -5.809770
H      -3.018718     -1.817729     -5.608377
H      -1.633963     -1.182591     -6.580595
H      -0.080406     -2.763845     -3.283980
H       0.045595     -2.769910     -5.077503
H      -1.471445     -3.342205     -4.277935
O      -6.807266      1.115812     -2.362653
O      -4.785770      3.128580      1.254541
O       0.094041     -0.697291     -1.473345
C       3.415564      0.253405      0.864121
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C       3.499768     -0.612663     -0.246821
C       2.380452     -0.911263     -1.006575
C       1.102970     -0.365648     -0.702765
C       1.019266      0.519068      0.432348
C       2.189965      0.804632      1.186176
C      -0.188562      1.170313      0.849063
N      -1.342006      0.996936      0.268285
N      -2.446738      1.679630      0.720259
C      -3.563037      1.552599     -0.041952
N      -3.532886      0.729612     -1.054875
Cu     -1.750578     -0.213753     -1.260323
O      -2.400334     -2.008000     -0.123252
N      -4.652187      0.570651     -1.819962
C      -5.832923      1.248531     -1.643406
N      -5.818999      2.115305     -0.536844
C      -4.760338      2.352582      0.315496
H      -0.130382      1.854263      1.695594
H      -2.363338      2.435445      1.391022
H      -4.525195     -0.031666     -2.622541
H      -6.680256      2.631448     -0.368227
H       4.298671      0.483503      1.454716
H       4.458165     -1.055195     -0.514083
H       2.447559     -1.575386     -1.860134
H       2.100261      1.478584      2.037108
S      -1.632835     -3.348191     -0.274267
C      -0.529028     -3.465156      1.167986
C      -2.825660     -4.631663      0.208531
H      -1.109907     -3.321965      2.085522
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H       0.222829     -2.677099      1.062607
H      -0.044499     -4.447614      1.156350
H      -3.244640     -4.387020      1.190428
H      -2.307692     -5.596625      0.229771
H      -3.611037     -4.645285     -0.553230
MODEL D, [CuL(DMSO)3]+ - Optimized structure
Coordinates from ORCA-job
O      -2.122556     -0.271557     -2.772047
S      -0.940660     -0.032970     -3.740268
C      -1.662360      0.771318     -5.204527
C      -0.553779     -1.641916     -4.501155
H      -2.002857      1.764115     -4.894639
H      -2.503987      0.173677     -5.571236
H      -0.884231      0.865578     -5.969954
H      -0.166533     -2.271356     -3.695122
H       0.211430     -1.490213     -5.270509
H      -1.464861     -2.071974     -4.931427
O      -6.945461     -1.315458      0.055699
O      -4.589620      2.355297      1.541651
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O       0.175248     -1.665155     -1.157212
C       3.677921      0.488112     -0.459591
C       3.681685     -0.771756     -1.097390
C       2.504262     -1.467809     -1.310160
C       1.240436     -0.950368     -0.905434
C       1.241498      0.334104     -0.246482
C       2.471255      1.019208     -0.045930
C       0.056419      0.985656      0.234609
N      -1.137662      0.473765      0.143863
N      -2.215168      1.158098      0.647643
C      -3.425120      0.560955      0.497284
N      -3.473466     -0.605573     -0.082856
Cu     -1.652195     -1.266611     -0.695752
O      -2.456486     -3.006168     -1.297805
N      -4.672655     -1.240735     -0.206556
C      -5.882345     -0.735625      0.197755
N      -5.781381      0.527476      0.806148
C      -4.628410      1.259745      1.008031
H       0.171681      1.960293      0.709530
H      -2.134114      2.101283      1.008671
H      -4.618182     -2.129355     -0.686765
H      -6.657062      0.936287      1.126195
H       4.606723      1.029008     -0.296088
H       4.624721     -1.205459     -1.427473
H       2.507308     -2.434739     -1.799535
H       2.442651      1.988724      0.450266
S      -1.802154     -4.357928     -0.839771
C      -1.946381     -5.404035     -2.315041
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C      -3.067900     -5.146402      0.192662
H      -1.641429     -6.420759     -2.044442
H      -1.263988     -4.998985     -3.068102
H      -2.979249     -5.384946     -2.677601
H      -3.157003     -4.518921      1.083110
H      -2.717127     -6.148822      0.461648
H      -4.012060     -5.196953     -0.359953
O      -1.663882     -2.523533      1.580854
S      -0.805600     -2.846309      2.818423
C       0.945452     -2.730947      2.324892
C      -0.852507     -1.371216      3.888734
H       1.563074     -2.900714      3.213849
H       1.149719     -1.749068      1.885560
H       1.125018     -3.518747      1.587348
H      -0.557060     -0.489117      3.310220
H      -0.175216     -1.529486      4.735181
H      -1.880789     -1.266012      4.247999
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Computed spin Hamiltonian values
In the following Tables, the main computed spin Hamiltonian values are given for the 
different models. The numbering of the nuclei is given in Scheme 6.
Table A1. Computed g tensors for the different models for CuIISODm in a DMSO:toluene solution.
gx gy gz
Model A 2.041 2.060 2.163
Model B 2.048 2.051 2.162
Model C 2.055 2.077 2.193
Model D 2.060 2.075 2.203
Table A2. Computed copper A tensors for the different models for CuIISODm in a DMSO:toluene 
solution.
Ax /MHz Ay /MHz Az /MHz
Model A 20.8 -31.8 -558.8
Model B 3.25 -10.68 -589.2
Model C 29.3 109.5 -522.0
Model D 50.8 99.7 -520.5
Table A3. Computed proton A tensors for Ha in the different models for CuIISODm in a 
DMSO:toluene solution. (Az is perpendicular to the L plane, Ax points in the direction of the copper 
ion).
Ax /MHz Ay /MHz Az /MHz
Model A 22.29 18.85 17.94
Model B 21.34 18.02 17.25
Model C 21.17 17.68 16.79
Model D 20.22 16.71 15.86
Table  A4.  Computed  proton  A  tensors  for  Hb in  the  different  models  for  CuIISODm  in  a 
DMSO:toluene  solution.  (Ax is  approximately  along  the  H-N  bond,  Az is  approximately 
perpendicular to the plane of L).
Ax /MHz Ay /MHz Az /MHz
Model A 11.07 6.73 5.62
Model B 11.44 6.93 5.85
Model C 9.68 5.14 4.17
Model D 9.98 5.50 4.52
93                           Enzyme Mimic to Develop Antioxidant Nanoreactors: From Synthesis to Application 
Appendix
Table  A5.  Computed  proton  A  tensors  for  Hc in  the  different  models  for  CuIISODm  in  a 
DMSO:toluene solution. (Ax is pointing towards the copper ion, Az is perpendicular to the plane of 
L).
Ax /MHz Ay /MHz Az /MHz
Model A 7.11 -0.65 1.13
Model B 6.24 0.27 -1.11
Model C 7.21 0.00 -0.06
Model D 7.27 0.74 -0.88
Table A6. Computed proton A tensors for Hd in the different models for CuIISODm in a 
DMSO:toluene solution. (Az is perpendicular to the plane of L, Ay is pointing in the direction of the 
copper ion)
Ax /MHz Ay /MHz Az /MHz
Model A -1.83 1.74 -2.61
Model B -1.80 2.10 -2.57
Model C -1.78 1.83 -2.50
Model D -1.71 1.82 -2.37
Table A7.  Computed nitrogen hyperfine and nuclear  quadrupole tensors for N1 in the different 
models for CuIISODm in a DMSO:toluene solution. (Az is perpendicular to the plane of  L,  Ay is 
pointing  in  the  direction  of  the  copper  ion.  The  largest  nuclear  quadrupole  coupling  is 
approximately  along  Ax,  the  smallest  nuclear  quadrupole  value  (in  absolute  value)  is  lying 
approximately perpendicular to the L plane)
Ax /MHz Ay /MHz Az /MHz e2qQ/h 
/MHz
η
Model A 45.03 58.40 46.96 3.775 0.412
Model B 45.86 59.75 47.89 3.779 0.396
Model C 41.76 54.44 43.70 3.779 0.530
Model D 41.68 53.97 43.55 3.826 0.600
Table A8. Computed nitrogen hyperfine and nuclear quadrupole tensors for N2 in the different 
models for CuIISODm in a DMSO:toluene solution. (Az and Pz are quasi perpendicular to the plane 
of L, 
Ax /MHz Ay /MHz Az /MHz e2qQ/h 
/MHz
η
Model A -0.02 -1.02 -1.92 -5.00 0.52
Model B -0.02 -1.04 -1.90 -5.03 0.53
Model C -0.24 -1.21 -2.01 -5.04 0.51
Model D -0.17 -1.04 -1.89 -5.09 0.49
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Table A9.  Computed nitrogen hyperfine and nuclear  quadrupole tensors for N5 in the different 
models for CuIISODm in a DMSO:toluene solution. (Az is perpendicular to the plane of  L,  Ay is 
pointing  in  the  direction  of  the  copper  ion.  The  largest  nuclear  quadrupole  coupling  is 
approximately  along  Ax,  the  smallest  nuclear  quadrupole  value  (in  absolute  value)  is  lying 
approximately perpendicular to the L plane).
Ax /MHz Ay /MHz Az /MHz e2qQ/h 
/MHz
η
Model A 39.27 49.14 40.95 3.680 0.298
Model B 36.46 45.96 38.07 3.708 0.288
Model C 34.23 43.22 35.80 3.731 0.457
Model D 33.98 42.71 35.55 3.786 0.508
Table A10. Computed nitrogen hyperfine and nuclear quadrupole tensors for N4 in the different 
models for CuIISODm in a DMSO:toluene solution. (Az and Pz are perpendicular to the plane of L, 
Px is approximately parallel to Ay).
Ax /MHz Ay /MHz Az /MHz e2qQ/h 
/MHz
η
Model A 1.07 0.10 0.34 -5.03 0.66
Model B 2.05 1.02 1.25 -5.22 0.60
Model C 1.78 0.83 1.05 -5.04 0.62
Model D 1.72 0.81 1.01 -4.96 0.61
Table A11. Computed nitrogen hyperfine and nuclear quadrupole tensors for N3 in the different 
models for CuIISODm in a DMSO:toluene solution. (Az is perpendicular to the plane of L, Pz lies 
along Ay, Py is approximately perpendicular to L)
Ax /MHz Ay /MHz Az /MHz e2qQ/h 
/MHz
η
Model A 0.10 -0.08 -0.11 -3.42 0.27
Model B 0.15 -0.03 -0.07 -3.43 0.28
Model C 0.13 -0.08 -0.04 -3.43 0.27
Model D 0.11 -0.06 -0.10 -3.43 0.26
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